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ABSTRACT 
 
Background: There is limited research available on the use of outcome measures in intensive care 
units (ICU) in a South African setting.The Chelsea Critical Care Physical Assessment tool (CPAx) is a 
measure of morbidity related to physical function and assesses respiratory function and functional 
abilities of critically ill patients. 
 
Objectives: The objectives of this study were to establish the effect of the use of the CPAx tool on ICU 
and hospital length of stay (LOS) in the care of critically ill patients; to establish the usefulness of the 
CPAx tool according to patient admission diagnosis; to determine if a relationship exists between CPAx 
scores and severity of illness or general morbidity during ICU admission; and to establish 
physiotherapists’ perceptions and views towards the use of the CPAx tool in their daily clinical practice 
in ICU. 
 
Design: The study consisted of two parts. Part one was a quasi-experimental design with a historical 
matched control group. Part two was a survey-based design.  
 
Methods: The study took place in a South African public sector hospital. Twenty six participants each 
were recruited into the experimental and control groups. Participants from the control group were 
matched with participants in the experimental group according to age, gender, diagnosis and acute 
physiology and chronic health evaluation (APACHE) II scores. CPAx scores and sequential organ failure 
assessment (SOFA) scores were calculated for participants in the experimental group on alternate 
weekdays during their ICU stay. Comparisons of ICU and hospital LOS between the study participants 
and historical control group were done using an independent t-test.  Pearson’s correlation coefficient 
was used to determine if a relationship existed between CPAx scores, APACHE II scores or SOFA 
scores. A p-value ≤ 0.05 was deemed statistically significant. A questionnaire was developed and was 
completed by the research assistants who administered the CPAx tool to participants in the experimental 
group in order to determine their perceptions of the tool.  
 
Results: The mean age for the CPAx group was 37.88 (±13.37) years and for the control group was 
37.81 (±12.21) years. The CPAx group consisted of 14 (53.8%) participants who underwent surgical 
procedures and 12 (46.2%) participants with traumatic orthopaedic injuries. The control group consisted 
of 14 (53.8%) participants who underwent surgical procedures and 12 (46.2%) participants with 
traumatic orthopaedic injuries. The mean initial SOFA score for the CPAx group was 2.42 (±1.79) and 
for the control group was 4.15 (±2.6). A p=0.03 indicates that there was a statistically significant 
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difference between the two groups with regards to initial SOFA scores. The mean SOFA score at ICU 
discharge for the CPAx group was 1.80 (±0.42) and for the control group was 2.87 (±1.81). A p=0.05 
indicates that there was a statistically significant difference between the two groups with regards to 
SOFA scores at ICU discharge.  
 
The mean initial CPAx score for the experimental group was 29.73 points (±14.81) and the mean CPAx 
score at ICU discharge was 36.15 (±8.33). The mean CPAx scores changed by 9.45 points between 
admission and discharge from ICU for participants who underwent surgical procedures and the mean 
CPAx scores changed by 3.9 points between admission and discharge from ICU for participants who 
sustained traumatic orthopaedic injuries. The mean ICU LOS for the CPAx group was 5.84 days (±7.43) 
and for the control group was 4.56 days (±5.25). The mean hospital LOS for the CPAx group was 17.43 
(±16.68) days and for the control group was 19.31 days (±15.79); however, in both cases differences 
were not statistically significant. 
 
APACHE II scores had a very weak negative correlation with initial CPAx scores. APACHE II scores 
had a very weak positive correlation with CPAx scores at ICU discharge. There was a statistically 
significant difference between the two groups with regards to initial SOFA scores (p=0.05). Initial SOFA 
scores had a statistically significant moderate negative correlation with initial CPAx scores (r=-0.45, 
p=0.02). Initial SOFA scores had a weak negative correlation with CPAx scores at ICU discharge. Initial 
CPAx scores had a moderate positive correlation with SOFA scores at ICU discharge. CPAx scores at 
ICU discharge had a very strong statistically significant positive correlation with SOFA scores at ICU 
discharge (r=0.80, p=0.05).The CPAx tool proved to be more responsive in a surgical population than 
in a trauma population. Clinicians had positive perceptions of the CPAx tool in the management of 
critically ill patients.  
 
Discussion: Participants in the CPAx group were well matched with those in the historical control group 
with regards to age, gender, diagnoses and severity of illness. Those in the CPAx group had lower 
extent of organ dysfunction than those in the control group which might account for their shorter period 
of hospitalisation. Patients with a higher risk for mortality on admission into the ICU displayed lower 
functional abilities and, in turn, lower CPAx scores were measured. A greater change in CPAx scores 
was observed for participants recovering from surgical interventions compared to those recovering from 
traumatic orthopaedic injuries. Participants with low morbidity at the time of ICU admission seemed to 
have a greater ability to perform functional activities during their ICU stay. Limitations of the study 
included a small patient sample, a limited number of research assistants as well as lack of content 
validation of the questionnaire used. A multi-centre trial on the use of CPAx in ICU patient management 
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could yield a wider perception of physiotherapists regarding the usefulness of the tool in daily clinical 
practice. Measuring the effect of the CPAx tool on participants’ length of mechanical ventilation could 
also be an interesting clinical outcome to consider.  
 
Conclusion: The data presented in this study show that the use of the CPAx tool does not have an 
influence on ICU and hospital LOS in a small sample of surgical and trauma participants. The tool 
appears to be more useful when used in the care of patients who are recovering from surgical 
procedures rather than those who sustained complex traumatic injuries. Physiotherapy clinicians that 
participated in the study supported the use of the CPAx tool in this single-centre trial and generally had 
positive perceptions towards the use of the tool.   
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CHAPTER 1 
1. INTRODUCTION 
 
1.1 BACKGROUND 
Recently there has been a growing worldwide trend towards early rehabilitation of patients in the 
intensive care unit (ICU) (Bailey, et al., 2007; Thomsen, et al., 2008; Truong, et al., 2009).This 
has been implemented in order to combat the negative effects associated with critical illness 
(Bailey, et al., 2007). There are very few rehabilitative outcome measures that can be used in 
ICU to measure patients’ functional abilities as the majority of them are not applicable in a critical 
care setting (Corner, 2012). The Chelsea Critical Care Physical Assessment tool (CPAx) is an 
outcome measure that assesses respiratory function as well as functional abilities of critically ill 
patients (Corner, et al., 2013). The aim of this study is to explore whether the use of CPAx in 
critically ill patients has an effect on their clinical outcomes. The second aim of this study is to 
determine physiotherapists’ perceptions towards the use of the CPAx tool in a South African ICU 
setting. 
 
Intensive care unit acquired weakness (ICU-AW) is a common debilitating condition associated 
with prolonged critical illness (Saxena and Hodgson, 2012). Risk factors include multiple organ 
dysfunction, sepsis and prolonged length of mechanical ventilation (Saxena & Hodgson, 2012). 
Common complications linked with ICU-AW include difficulty with weaning from mechanical 
ventilation, increased hospital length of stay (LOS), long term functional impairments and 
disability as well as reduced health-related quality of life (Corner, 2012). 
 
Marques et al. (2006) states that outcome measures are vital in order to determine patients’ 
responses to treatment given, to evaluate the usefulness of the treatment given as well as to 
make a comparison between different treatment interventions. In a study performed by Maher 
and Williams (2005) that examined factors influencing physiotherapists’ use of outcome 
measures in the management of patients who underwent a lung transplant, it was found that 
83% of physiotherapists do not use outcome measures as part of their routine patient 
management due to time constraints as well as lack of equipment. Although there are many 
rehabilitation tools used to measure physical disability, functional outcome measures are not 
commonly used by physiotherapists in critical care settings (Corner, 2012).  Most rehabilitation 
tools are time consuming to use, lack specificity and are not appropriate for patients in the ICU 
(Corner, 2012). 
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The CPAx tool is an outcome measure designed to assess 10 domains of physical ability 
including: respiratory function, cough, bed mobility, supine to sitting on the edge of the bed, 
dynamic sitting, sit to stand, standing balance, transferring from bed to chair, stepping and grip 
strength (Corner, et al., 2013). Each domain is graded from 0 (complete dependence) to 5 
(complete independence) (Corner, et al., 2014). A total score out of 50 is then obtained and is 
depicted in pictorial form on a “radar” or “spider diagram” chart. The tool is simple to use and 
was designed as a bed-side scoring system in order to monitor patients’ functional abilities and 
identify problem areas daily (Corner, et al., 2013). Once problem areas have been identified, a 
specific rehabilitation programme can be designed to meet the needs of the patient (Corner, et 
al., 2013).  
 
Although it is important to measure function in the ICU, it is also vital to be able to measure 
patients’ risk for morbidity and mortality. The Acute Physiology and Chronic Health Evaluation 
(APACHE II) score was designed to assess a patient’s physiological state and is used as a 
predictor of mortality in critically ill patients in the first 24 hours following admission into the ICU 
(Dosset, et al., 2009; Mica, et al., 2013; ClinCalc.com, 2015). Numerical scores are assigned to 
different clinical and biochemical domains including white cell count, Glascow Coma Scale 
(GCS), temperature, mean arterial blood pressure, haematocrit, heart rate, respiratory rate, 
oxygenation, arterial pH, serum potassium, serum sodium and serum creatinine (Dosset, et al., 
2009; ClinCalc.com, 2015). High scores indicate an increased illness severity and therefore a 
higher risk for mortality (Dosset, et al., 2009). The Sequential Organ Failure Assessment (SOFA) 
score is commonly used to determine the degree of organ dysfunction and sepsis severity of 
patients in intensive care units (Bale, et al., 2013). The SOFA score assesses function of six t 
organ systems namely the respiratory, coagulation, renal, liver, cardiovascular and neurological 
systems (Bale, et al., 2013). The tool is a useful predictor of morbidity in critical care (Bale,et al., 
2013; ClinCalc.com, 2014).  
 
In a validation pilot study performed by Corner et al. (2013), CPAx was shown to have a 
significant negative correlation with patients’ SOFA scores. This suggests that as patients’ CPAx 
scores increase, so their risk for organ dysfunction is reduced (Corner, et al., 2013). The study 
also revealed that the higher patients’ CPAx scores are, the shorter the length of mechanical 
ventilation becomes (Corner, et al., 2013). This information may be the building block for this 
study which looks to assess whether the use of CPAx in the treatment of critically ill patients has 
an effect on length of stay (LOS) in ICU and in the hospital. 
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1.2 STATEMENT OF PROBLEM AND JUSTIFICATION FOR RESEARCH 
To date rehabilitation-based outcome measures have not been well utilised in South African 
physiotherapy ICU practice. This may be due to time constraints and high patient caseloads but 
this has not been confirmed through research. It is important to identify a suitable outcome 
measure that is easy to administer to patients in ICU and assists physiotherapy clinicians to 
identify individual patient needs and develop appropriate goal-directed physiotherapy 
interventions to improve the clinical outcomes of patients in a South African ICU setting. By 
assessing physical function of critically ill patients, goal-orientated early mobilisation and 
rehabilitation is encouraged. The CPAx tool seems to be a user-friendly and an easily 
understandable tool to use in the ICU setting. 
 
1.3 RESEARCH QUESTIONS 
1.3.1  Does the use of the CPAx tool in the care of critically ill patients have an influence on their clinical 
outcomes?  
 
1.3.2  What are physiotherapists’ perceptions and views towards the use of the CPAx tool in the care 
of critically ill patients? 
 
1.4 SIGNIFICANCE OF RESEARCH 
There is evidence that shows that early mobilisation of patients in ICU significantly reduces the 
harmful effects of prolonged critical illness (Bailey, et al., 2007; Thomsen, et al., 2008; Truong, 
et al., 2009). Use of the CPAx tool as part of physiotherapy patient management in ICU has been 
shown to have a negative correlation with length of mechanical ventilation and morbidity (Corner, 
et al., 2013). The CPAx is easy to use and assists physiotherapy clinicians to assess physical 
function of patients in a general intensive care unit setting (Corner, et al., 2013). By measuring 
patients’ functional progress objectively through assessment of CPAx scores, patient specific 
rehabilitation goals can be created to ensure appropriate progression of rehabilitative care which 
may improve clinical outcomes such as ICU and hospital LOS. This study investigates the effect 
of the CPAx tool on the clinical outcomes of patients who underwent surgical procedures or who 
sustained traumatic injury and were admitted to ICU. The incidence of trauma in South Africa is 
high and a large number of patients with trauma-related injury or surgery are regularly admitted 
to the critical care division of Chris Hani Baragwanath Academic hospital. If it is found that the 
use of the CPAx tool as part of physiotherapy management of patients in these ICUs impacts 
positively on patients’ clinical outcomes and is perceived to be easy to administer, its use in other 
South African ICU populations may be encouraged.  
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1.5 RESEARCH AIMS 
 To determine if the use of the CPAx tool in the care of critically ill patients has an influence 
on their clinical outcomes. 
 
 To determine physiotherapists’ perceptions and views towards the use of the CPAx tool in 
the care of critically ill patients. 
 
1.6 RESEARCH OBJECTIVES 
 To establish the effect of the use of the CPAx tool on LOS in ICU and in the hospital in the 
care of critically ill patients. 
 
 To establish the usefulness of the CPAx tool according to patient admission diagnosis. 
 
 To determine if a relationship exists between scores obtained from the CPAx tool and those 
obtained from the APACHE scoring system. 
 
 To determine if a relationship exists between scores obtained from the CPAx tool and those 
obtained from the SOFA scoring system. 
 
 To establish physiotherapists’ perceptions and views towards the use of the CPAx tool in 
their daily clinical practice in ICU. 
 
1.7 TYPE OF STUDY 
The study consisted of two parts. Part one was a quasi-experimental design with a historical 
matched control group. Part two was a survey-based design.  
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CHAPTER 2 
 
2. LITERATURE REVIEW 
Information shared in this literature review was identified through searches performed on the 
following search engines: Google Scholar, Science Direct, Clinical Key, EBSCO Host (CINAHL 
Plus), PubMed, Springer Link and Scopus. The following search terms were used: ‘CPAx’, 
‘Chelsea Critical Care Physical Assessment tool’, ‘early mobilisation in ICU’, ‘benefits of early 
mobilisation in ICU’, ‘intensive care unit acquired weakness’, ‘ICU-AW’ ‘APACHE’, ‘SOFA’, 
‘SAPS’, ‘injury severity scores’, ‘physiotherapy + outcome measures + ICU’ ‘rehabilitation 
outcome measures in ICU’, ‘organ dysfunction scores in ICU’. English language articles were 
sourced and used. 
 
The burden of disease in developing countries such as South Africa is a growing concern. As 
patient management improves, there are more survivors of critical illness than there were in the 
past (Schweickert & Kress, 2011). This in turn has resulted in the emergence of conditions such 
as intensive care unit acquired weakness which leads to severe long-term functional 
impairments (Schweickert & Kress, 2011). We are constantly searching for ways to improve 
provision and monitoring of health care services in our country. Where resources and funds 
allow, physiotherapists in South Africa seem to be following trends in current research especially 
with regards to management of patients in the intensive care unit. Although early mobilisation in 
the ICU has been researched in this country, the number of studies in this area is limited. 
Outcome measures are tools that are under-utilised in South African hospitals particularly in the 
public sector. To the researcher’s knowledge, there are no South African studies available that 
examine the use of rehabilitative outcome measures in the management of critically ill patients.  
 
2.1 COMPLICATIONS OF BED REST AND CRITICAL ILLNESS 
Immobility has been associated with many complications including those of the respiratory 
system (Goldhill, et al., 2007). The respiratory complications experienced by immobile patients 
in the ICU include pneumonia, atelectasis, pulmonary emboli and acute respiratory distress 
syndrome (Goldhill, et al., 2007). 
 
Intensive care unit acquired weakness is also a well-known complication of critical illness 
associated with severe short term and long term functional limitations (Schweickert and Kress, 
2011; Thrush, et al., 2012; Wieske, et al., 2015). Due to increasing numbers of ICU survivors, 
more health care workers are being exposed to patients with ICU-AW outside of the ICU (Kress 
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& Hall, 2014). This means that more post-ICU rehabilitation is taking place (Kress & Hall, 2014).  
Intensive care unit acquired weakness can be defined as generalised muscle weakness that has 
developed in the absence of any condition or diagnosis aside from the underlying critical illness 
(Stevens, et al., 2009). Intensive care unit acquired weakness affects skeletal muscle including 
the diaphragm (Li, et al., 2013).  Intensive care unit acquired weakness has been associated 
with risk factors such as poor glycaemic control, sepsis, multi-organ failure, mechanical 
ventilation, glucocorticoid use and exposure to neuromuscular blocking agents (Stevens, et al., 
2009). Assessment of patients with ICU-AW reveals symmetrical limb and diaphragm weakness 
and decreased muscle tone (Stevens, et al., 2009). Deep tendon reflexes may be normal, 
reduced or absent; however, cranial nerves are normally spared (Stevens, et al., 2009). These 
patients often suffer from associated respiratory failure and are generally difficult to wean from 
mechanical ventilation (Stevens, et al., 2009; Kress and Hall, 2014).  
 
Critical illness polyneuropathy (CIP) and critical illness myopathy (CIM) are pathological 
processes associated with ICU-AW. Patients that are diagnosed with CIP have the same 
symptoms as those diagnosed with ICU-AW as well as electrophysiological evidence of a 
sensorimotor axonal polyneuropathy (Stevens, et al., 2009). Such evidence includes reduced 
amplitude of compound muscle action potentials and sensory nerve action potentials with normal 
or slightly decreased conduction velocity of the nerves (Batt, et al., 2013). Primary axonal 
degeneration of peripheral nerve sensory and motor fibres occurs in CIP (Batt, et al., 2013). 
Creatine kinase levels are normal in these patients (Kress & Hall, 2014).  Patients with CIP 
present with distal loss of pain, temperature, proprioception and vibration sensation; and deep 
tendon reflexes are either absent or reduced (Stevens, et al., 2009; Batt, et al., 2013).  Critical 
illness myopathy has been described as a form of skeletal muscle dysfunction that occurs as a 
result of reduced muscle mass and impaired contractility combined (Batt, et al., 2013). Muscle 
atrophy occurs as a result of a discrepancy between muscle proteolysis and protein synthesis 
with a remarkable loss of myosin relative to actin (Batt, et al., 2013). Problems with muscle 
contractility and force generating capacity in CIM may occur due to oxidative stress, 
mitochondrial dysfunction, lack of mucous membrane excitability and impaired excitation-
contraction coupling (Batt, et al., 2013). Patients with CIM have elevated serum creatine kinase 
levels, weak and flaccid limbs, reduced or normal deep tendon reflexes and difficulty in weaning 
from mechanical ventilation; however the patient’s sensation is spared (Batt, et al., 2013)   It has 
been suggested that CIM and CIP do not occur in isolation but form rather an integral part of the 
processes associated with multiple organ dysfunction (Batt, et al., 2013).  
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In a study by Wieske et al. (2015), the authors compared post-ICU mortality and physical 
functional levels between patients with and without ICU-AW at six months post discharge. 
Intensive care unit acquired weakness was associated with lower functional abilities and higher 
mortality rates at six months following ICU discharge (Wieske, et al., 2015).  
 
Intensive care unit acquired weakness is a multi-factorial process and it has strong associations 
with prolonged bed rest and immobility (Li, et al., 2013). Historically, mechanically ventilated 
patients are kept in bed partly due to the severity of their underlying illness as well as sedation 
protocols that are followed (Li, et al., 2013). Early mobilisation of critically ill patients is a concept 
in its infancy that is becoming a global trend in an effort to combat the negative effects of bed 
rest and immobility (Amidie, 2012). It could potentially be used to prevent ICU-AW provided that 
the patients are physiologically stable and that there are no contraindications to early 
mobilisation (Hanekom, et al., 2011; Amidie, 2012). 
 
2.2 EARLY MOBILISATION OF PATIENTS IN ICU 
There have been multiple studies published investigating the safety, practicality and benefits of 
early mobilisation of critically ill patients (Bailey, et al., 2007; Morris, et al., 2008). Bailey et al 
(2007) investigated the feasibility of early activity in patients with respiratory failure that required 
mechanical ventilation and also considered the safety associated with it. The results of their 
prospective cohort study showed that early mobilisation is a candidate therapy that can be used 
to prevent the neuromuscular complications associated with critical illness (Bailey, et al., 2007). 
After performing a prospective cohort study, Morris et al. (2008) concluded that early 
rehabilitation is safe and feasible, does not increase hospital costs and is also associated with 
reduced ICU LOS and hospital LOS. Clark et al. (2013) suggested that early mobilisation of 
patients in a trauma/burns population is also safe and effective. This rehabilitation strategy can 
also lead to reduced airway, pulmonary and vascular complications (Clark, et al., 2013). 
 
Hanekom et al. (2011) used 28 draft algorithm statements to develop an evidence-based clinical 
management algorithm for early rehabilitation and mobilisation of critically ill patients. The 
authors achieved this using an electronic three round Delphi process (Hanekom, et al., 2011). 
The algorithm was developed by an international inter-professional panel, is the first of its kind 
and has been cited by many researchers since its publication (Hanekom, et al., 2011).  
 
Introduction of an early rehabilitation team in a European ICU was associated with improved 
patient mobility at ICU discharge, decreased mechanical ventilator days, reduced ICU length of 
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stay and reduced hospital length of stay (McWilliams, et al., 2015). Schweickert et al. (2009) 
established that early physiotherapy and occupational therapy combined with breaks in sedation 
are associated with better functional outcomes, shorter period of delirium and shorter duration 
of mechanical ventilation. It has also been shown that early rehabilitation of critically ill patients 
is safe and well tolerated with few adverse incidents (Bailey, et al., 2007; Schweickert, et al., 
2009). Although early mobilisation strategies in ICU are part of a growing global clinical and 
research trend, the use of functional/rehabilitation outcome measures in ICU is minimal(Corner, 
2012). The efficacy of early mobilisation of critically ill patients in specific patient populations 
needs to be further researched using appropriate outcome measures and instrumentation (Li, et 
al., 2013). 
 
2.3 REHABILITATION OUTCOME MEASURES IN ICU 
Outcome measures are used to evaluate the effectiveness of patient management (Maher & 
Williams, 2005). Maher and Williams (2005) examined the outcome measures used by 
physiotherapy clinicians in the care of patients who underwent lung transplants in Australia and 
New Zealand. The authors also investigated the factors that have an influence on the use of 
outcome measures in this patient group (Maher & Williams, 2005). A cross-sectional, descriptive 
qualitative design was used to survey the clinicians working with the above-mentioned patients 
(Maher & Williams, 2005). Results of the study showed that time constraints, lack of reliability 
and validity and equipment requirements were the most commonly reported problems with 
outcome measure use in the study (Maher & Williams, 2005). The most commonly reported 
outcome measures were those used to assess exercise tolerance, dyspnoea and the ability to 
carry out activities of daily living (Maher & Williams, 2005).  
 
According to Corner (2012) and Bisset et al (2016), there is a wide variety of outcome measures 
available to assess physical disability; however, these are problematic when used in a population 
of critically ill patients. These tools lack specificity as they were not designed for patients in a 
critical care setting (Corner, 2012). There are a few measures available; however, most of the 
current tools are yet to be tested for validity or reliability (Corner, 2012). Intensive care unit 
acquired weakness significantly contributes to disability in the critical care population which 
results in many of the available outcome measures having a significant “floor effect” (Corner, 
2012). This means that most of the tools available are not able to identify changes in patients 
that have lower functional levels (Corner, 2012). A valid and reliable outcome measure designed 
for the critical care population should be able to detect small changes in patients’ functional 
abilities (Corner, 2012). To date there is no ‘gold standard’ to measure exercise capacity in 
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critically ill patients (Skinner, et al., 2009). There is currently a need for a bedside tool that can 
facilitate assessment, guide rehabilitation strategies and help to monitor patients’ progress 
during their stay in ICU (Corner, 2012). 
 
The ICU mobility scale (IMS) is an assessment tool that was designed to enable physiotherapists 
to report on their patients’ functional abilities (Hodgson, et al., 2014). The tool is unique as it 
assesses various levels of function as well as describing the amount of assistance that the 
patient required in order to successfully complete a functional task (Hodgson, et al., 2014). 
Hodgson et al. (2014) found that the tool is effective and feasible to measure functional abilities 
of critically ill patients and has strong inter-rater reliability for recording patients’ maximum levels 
of mobility during the day. The authors admitted that validation of the tool in future research is 
needed (Hodgson, et al., 2014). The IMS is quick to administer and is simple to understand; 
however, it has been described as having floor effects when used in the assessment of critically 
ill patients (Hodgson, et al., 2014; Parry et al., 2015).  
 
The Functional Independence Measure (FIM) is a tool created to achieve a more general 
functional assessment of a patient (Corner, 2012). The tool tests patients on 18 different 
functional cognitive tasks and requires input from all members of the multidisciplinary team 
(DiCicco and Whalen, 2010; Corner, 2012). The psychometric properties of the tool have been 
tested in a population with varying diagnoses  including multiple sclerosis, stroke and general 
rehabilitation groups (Corner, 2012). It has been proved to be a valid and reliable outcome 
measure in a general population; however, its use in a critical care setting has not been 
substantially investigated (DiCicco and Whalen, 2010; Corner, 2012). The tool is also time 
consuming to administer which can be problematic in a busy ICU (Corner, 2012). The tool does 
not account for changes in a patient’s medical condition nor the interruptions by other health 
professionals that commonly occur (DiCicco & Whalen, 2010). DiCicco and Whalen (2010) 
described the significant floor effects of the FIM as it is unable to detect  small improvements in 
function in critically ill patients. Another downfall of the FIM is that it does not account for patients 
who are not yet physiologically stable for activity and mobilisation (DiCicco & Whalen, 2010). 
 
The University of Rochester Acute Care Evaluation (URACE) was designed with efficiency in 
mind (DiCicco & Whalen, 2010). The tool consists of activities that would normally be included 
in a standard physiotherapy assessment so no extra time would be required to administer it to 
the patients (DiCicco & Whalen, 2010). These activities include moving from supine to sitting, 
transfers, locomotion and stair climbing (DiCicco & Whalen, 2010). Scoring is achieved by simply 
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circling the correct score for each assessed activity; however, the tool has no total score which 
means it cannot be statistically compared to other outcome measures (DiCicco & Whalen, 2010). 
Although the tool is useful in a  critically ill patient population, it has not been validated to date 
and its reliability has not been tested (Pawlik & Kress, 2013). The tool does not account for basic 
bed mobility assessment criteria such as rolling in the bed and is not suitable for patients that 
are not able to mobilise into sitting (DiCicco and Whalen, 2010; Pawlik and Kress, 2013).  
 
The Functional Status Score for the Intensive Care Unit (FSS-ICU) is a novel measure based on 
the scoring structure of the FIM (Zanni, et al., 2010). The tool consists of five functional tasks: 
rolling, transferring from supine to sitting, sitting on the edge of the bed, sit to stand and 
ambulation (Zanni, et al., 2010). Each activity is scored from one to seven with one representing 
total assistance and seven representing total independence with a higher score indicating a 
higher level of function (Zanni, et al., 2010; Thrush, et al., 2012). The FSS-ICU was first used in 
a small pilot study to describe functional deficiencies of patients receiving rehabilitation in ICU 
(Zanni, et al., 2010). Thrush et al. (2012) investigated the clinical utility of the FSS-ICU in a long 
term acute care setting and also examined the association between FSS-ICU score and 
discharge location. Results of the study showed that the FSS-ICU is able to discriminate between 
different discharge settings and is able to successfully document functional changes in patients 
in a long term acute care setting (Thrush, et al., 2012). 
 
The Physical Function in Intensive Care Test (PFIT) was designed specifically for the critical 
care population as these patients may never have the ability to perform sub-maximal exercise 
testing while they are still in ICU (Nordon-Craft, et al., 2014).  The tool was designed to identify 
endurance, muscle strength, cardiovascular capacity and functional ability (Skinner, et al., 2009). 
The assessment includes sit-to-stand, marching on the spot, shoulder flexion for as long as 
possible and muscle strength testing for knee extension and shoulder flexion (Skinner, et al., 
2009). The PFIT demonstrates responsiveness to change over time provided that it is used in 
conjunction with a rehabilitation programme (Skinner, et al., 2009). It is easy to administer and 
is reliable when used in a critically ill population (Skinner, et al., 2009). The PFIT has been said 
to demonstrate face validity; however, it is difficult to formally validate the tool (Skinner, et al., 
2009). The PFIT requires the patient to be awake and able to follow instructions. 
 
The Short Physical Performance Battery (SPPB) test was designed to assess physical function 
in the elderly population (Gomez, et al., 2013). It is a valid and reliable measure to assess 
physical performance in elderly people. It is also easy to administer and safe to use (Gomez, et 
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al., 2013). The SPPB consists of three measures: gait speed over a four metre course, time 
taken to complete five chair raises without the use of arm rests and a standing balance test 
(Chmelo, et al., 2015). Although it is responsive to change, the SPPB has floor effects which 
may limit its effectiveness in assessment of elderly patients in ICU (Parry, et al., 2015). The 
SPPB has not been validated for use across a wider age-range of patients (Gomez, et al., 2013). 
 
Parry et al. (2015) found that the FSS-ICU, IMS and the SPPB had high criterion validity when 
compared to the Physical Function in Intensive Care Test-scored (PFIT-s). In the same study it 
was found that patients that had higher PFIT-s scores on awakening in ICU were more likely to 
be discharged home directly (Parry, et al., 2015). Parry et al. (2015) suggested that both the 
FSS-ICU and the PFIT-s are promising outcome measures that should be considered as part of 
a standard ICU assessment.   
 
The Acute Care Index of Function (ACIF) was designed to measure the physical function of 
people with neurological injury; however, it may demonstrate usefulness in other patient 
populations (Bisset, et al., 2016). The tool consists of four domains namely mental status, bed 
mobility, transfers and mobility (Bisset, et al., 2016). The tool was shown to have good construct 
validity, is easy to administer and requires minimal training of healthcare professionals before its 
use (Bisset, et al., 2016). Bisset et al. (2016) investigated the use of the ACIF in an ICU 
population as well as the relationship between the ACIF and the FIM. The ACIF demonstrated 
excellent inter-rater reliability in a cohort of mixed surgical/medical/trauma ICU patients and 
strongly correlates with the FIM (Bisset, et al., 2016). Acute Care Index of Function scores can 
also be used by physiotherapists to describe the functional improvements of their patients 
especially those with a prolonged ICU stay (Bisset, et al., 2016). The tool is yet to be validated 
for its use in a critically ill population (Bisset, et al., 2016). 
 
The Chelsea Critical Care Physical Assessment (CPAx) tool was developed by Evelyn Corner 
and is one of the newest outcome measures designed for the assessment of physical morbidity 
in critically ill patients (Corner, 2012). The tool is a numerical and illustrative scoring system that 
evaluates ten different components of physical function including respiratory function, cough 
effort, bed mobility, supine to sitting on the edge of the bed, sitting balance, sit to stand, transfers 
from  bed to chair, standing balance, stepping and grip strength (Corner, 2012; Corner, et al., 
2014; Corner, et al., 2015). Each component is scored from zero to five on a Guttman scale with 
zero representing full dependence and five full independence (Corner, 2012; Corner, Soni, 
Handy, and Brett, 2014; Corner, et al., 2015). A total score out of 50 is acquired (Corner, 2012). 
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The scores are depicted on a radar chart giving a quick pictoral indication of the patient’s 
functional ability as well as clearly indicating functional components that can be considered 
problematic (Corner, et al., 2014). The tool was specifically designed to detect changes in low 
functioning patients (Corner, et al., 2015). What makes the CPAx unique is that it includes 
assessment of cough effort and respiratory parameters and not just general functional activities 
like the other rehabilitation outcome measures described above. In light of the respiratory 
complications that often occur in critically ill immobilised patients, CPAx would therefore appear 
to be the outcome measure of choice.  
 
Corner et al. (2013) performed a proof-of-concept pilot study in the United Kingdom in order to 
test the validity of the CPAx tool. The study consisted of four parts: development of the CPAx 
tool, a focus group, content validity indices (CVI) questionnaire and an observational cohort 
study component (Corner, et al., 2013). The observational study was performed to test construct 
validity of CPAx against the Medical Research Council (MRC) score for muscle strength, peak 
cough flow, Australian Therapy Outcome Measure (AusTOMs) score, Glasgow Coma Scale 
score, Bloomsbury sedation score, Sequential Organ Failure Assessment (SOFA) score, 36 Item 
Short Form Health Survey(SF-36) score and mechanical ventilator days (Corner, et al., 2013). 
The prospective cohort consisted of 33 general and trauma patients in the critical care unit (CCU) 
(Corner, et al., 2013). The author of the study did not elaborate on the specific type of trauma 
that the participants had sustained prior to admission into the CCU. The results of the study 
showed strong inter-rater reliability and internal consistency (Corner, et al., 2013). The CPAx 
tool demonstrated significant negative correlation with the SOFA score and the duration of 
mechanical ventilation as well as moderate to strong positive correlation with GCS score, 
sedation score, muscle strength, AUSTOMs score, peak cough flow score and the SF-36 score 
(Corner, et al., 2013). The combination of these results suggests validity of the CPAx tool in the 
assessment of physical morbidity (Corner, et al., 2013).  
 
A strong association between CPAx scores at discharge from ICU and hospital discharge setting 
was established in a study in 2014 which implies construct validity of the tool (Corner, et al., 
2014). When designing the study, the authors hypothesised that higher CPAx scores on ICU 
discharge would be associated with improved functional outcomes indicated by discharge 
location (Corner, et al., 2014).  Following the study it was also established that CPAx has a 
limited floor and ceiling effect in the management of general ICU patients (Corner, et al., 2014). 
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The CPAx tool was also shown to be effective in the management of specialist trauma patient 
populations such as burns (Corner, et al., 2015). Corner et al. (2015) performed an observational 
study to analyse the responsiveness of CPAx in the adult burns population. The study was 
performed at a small specialist burns ICU in central London (Corner, et al., 2015). The CPAx 
scores of 52 patients with burn injuries in intensive care were taken retrospectively at pre-
admission into ICU, prospectively at ICU admission, ICU discharge and hospital discharge 
(Corner, et al., 2015). Scores were not taken over the weekends due to the logistics of teaching 
non-specialist clinicians in the use of the CPAx tool (Corner, et al., 2015). Results showed that 
CPAx is effective in detecting variations in physical function and that it has a limited floor and 
ceiling effect when used in critically ill patients with burn injuries (Corner, et al., 2015). It was 
concluded that a change in CPAx score of more than six represents the minimal clinically 
important amount of progress made by patients (Corner, et al., 2015). The authors admitted that 
further research is needed in order to test the validity of CPAx in the burns population in a larger 
cohort of patients across multiple locations (Corner, et al., 2015).  
 
2.4 ORGAN DYSFUNCTION SCORES 
Organ dysfunction scores are used to predict patients’ severity of illness and to statistically 
describe the extent of their injuries (Giannoni, et al., 2013). Severity scores are also used in 
research to demonstrate equivalency of control and study participants (Zimmerman, et al., 2006). 
 
The SOFA score quantifies daily organ dysfunction by measuring 14 physiological variables from 
six organ systems namely the respiratory, renal, cardiovascular, liver, haematological and 
neurological systems (Ulvik, et al., 2007). Each system is given a score ranging from zero to four 
according to the degree of dysfunction (Bhattacharyya, et al., 2011). The SOFA score is used to 
evaluate the degree of organ dysfunction over time (Ferreira, et al., 2001). The tool is said to be 
a useful predictor of morbidity and mortality (Ferreira, et al., 2001; Fueglistaler, et al. 2010). The 
Sequential Organ Failure Assessment is based on fewer physiological parameters than other 
scores such as the Simplified Acute Physiology Score (SAPS) and the APACHE score and also 
does not include information on the reason for admission into the ICU or co-morbidities (Minne, 
et al., 2008). Bhattacharyya et al (2011) stated that patients who obtain lower SOFA scores are 
more likely to be weaned from mechanical ventilation. This in turn suggests that SOFA scores 
can be useful in predicting the outcome of mechanically ventilated patients (Bhattacharyya, et 
al., 2011).  Moreno et al. (1999) investigated the performance of the total maximum SOFA score 
and a derived measure (delta SOFA). Results of their study suggested that the total maximum 
SOFA score and the delta SOFA score (total maximum SOFA score minus admission total SOFA 
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score) can be used to calculatethe degree of organ dysfunction at ICU admission, the amount 
of dysfunction during the patient’s hospital stay as well as the cummulative injuries suffered by 
the patient (Moreno, et al., 1999). 
 
Ferreira et al. (2001) investigated the usefulness of the SOFA score to predict mortality of 
critically ill patients in ICU. The authors found that the SOFA score is a good prognostic indicator 
and that an increase in the SOFA score during the first 48 hours of admission into the ICU is 
able to predict a mortality rate of 50% (Ferreira, et al., 2001). Arts et al. (2005) performed a 
prospective study with 30 randomly selected patient cases and 20 ICU doctors to examine the 
accuracy and reliability of the SOFA scoring system. Results of the study showed that the 
accuracy and reliability of the SOFA score amongst physicians in the ICU is good (Arts, et al., 
2005).  
 
Minne et al. (2008) completed a systematic review to assess the performance of the SOFA score 
for predicting mortality in a critically ill patient population. According to their results, the authors 
concluded that performance models based on the SOFA score is comparable with that of other 
organ failure scores (Minne, et al., 2008). Minne et al. (2008) advocated the use of a traditional 
score based on information obtained during the first 24 hours of admission into ICU (e.g. 
APACHE) with sequential scores (such as SOFA) across the entire ICU stay. 
 
Nair et al. (2016) performed a study to determine if the initial SOFA score is a superior predictor 
of mortality than the SAPS score. Simplified Acute Physiology Score measures 14 biological and 
clinical variables to predict mortality of patients admitted into ICU (Le-Gall, et al., 1984). Results 
of the study showed that SOFA was found to be a more superior mortality predictor (Nair, et al., 
2016). When compared with the SOFA score, the SAPS was found to lack sensitivity whereas 
the initial SOFA score was found to be sensitive and specific (Nair, et al., 2016).  
The APACHE is an injury prediction score that was designed according to the theory that the 
severity of acute disease can be established by quantifying the degree of irregularity of multiple 
organ systems (Knaus, et al., 1985). The APACHE II system was designed as a revised version 
of the APACHE system (Knaus, et al., 1985). The score was designed as a way to predict 
mortality (Minne, et al., 2008) and the maximum score attainable is 71 (Knaus, et al., 1985). The 
system assigns numerical values to 12 physiological parameters including: mean arterial blood 
pressure, haematocrit, temperature, heart rate, respiratory rate, oxygenation, arterial pH, serum 
sodium, serum potassium, serum creatinine, white blood cell count and GCS (Dossett, et al., 
2009). The APACHE II utilises the worst physiological parameters recorded during the first 24 
15 
 
hours following admission into the ICU (Dossett, et al., 2009). It should be noted that the 
APACHE II score is an accurate predictor of clinical outcomes in critically injured trauma patients 
(Dossett, et al., 2009). The APACHE II score has not been validated for use outside of the first 
24 hours following admission into the ICU (Ferreira, et al., 2001).  
 
The APACHE II scores have been used as a mechanism to match participants in previous 
studies (Beattie, et al., 2012). In a study published in 2012, the authors performed a retrospective 
review to describe the population of people who developed ventilator acquired pneumonia (VAP) 
bundles (Beattie, et al., 2012). The study also aimed to assess the degree to which VAP bundle 
compliance limited the risk of acquiring VAP (Beattie, et al., 2012).Ten cases were examined 
and each case was matched with two controls according to age, gender, APACHE II score and 
number of ventilator days (Beattie, et al., 2012). With regards to matching of participants, cases 
were matched according to APACHE II scores within a range of five points (Beattie, et al., 2012).  
 
Dossett et al. (2009) revisited the validation of the APACHE II score in a prospective study that 
examined a population of critically injured patients. Severity scores were collected and in-
hospital mortality was predicited (Dossett, et al., 2009). When compared with the Trauma Injury 
Severity Score and the Injury Severity Score, the APACHE II was found to be a greater predictor 
of mortality in critically ill trauma patients that required longer than 48 hours stay in the intensive 
care unit (Dossett, et al., 2009). This could be due to the fact that the APACHE II is a more 
generalised scoring system with a significant physiologic basis when compared to traditional 
trauma scores (Dossett, et al., 2009). 
 
Polderman et al. (2001) examined the accuracy and reliability of the APACHE II scoring system 
in a retrospective review. The authors found that various causes of error and extensive variability 
exist when the APACHE II is used in everyday patient management (Polderman, et al., 2001). 
The APACHE II was shown to lack reliability in this study (Polderman, et al., 2001). It should 
also be noted that the APACHE II score tends to overestimate mortality risk in ICU patients 
(Polderman, et al., 2001). In the ICU at Chris Hani Baragwanath Academic hospital, the APACHE 
II is the scoring system used to predict injury severity on admission into the unit. It is on this 
basis that the APACHE II was used in the current study. 
 
2.5 CONCLUSION 
There is little literature available on early mobilisation of critically ill patients in South African 
intensive care units. There is also currently a gap in the literature with regards to the use of valid 
16 
 
and reliable rehabilitative outcome measures in the ICU, especially in the South African context. 
Prolonged hospital and ICU LOS results in impaired physical function of patients and increased 
costs to the hospital involved. There is a need to examine the use of outcome measures, such 
as the CPAx tool, in order to determine if it will aid in reducing patients’ ICU and hospital LOS. It 
is also vital to find a functional outcome measure that is cost effective, quick to administer and 
user-friendly when used in a critically ill patient population. 
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CHAPTER 3 
 
3. METHODOLOGY 
The methodology discussed in this chapter is based on the findings of the literature review 
discussed in Chapter 2. The study design, sample population, inclusion and exclusion criteria as 
well as instrumentation and data collection procedure used during the study are discussed in 
detail. An explanation of the pilot study, its aims, methodology and its implications on the main 
study procedure is given. The methods for data analysis are given as well as the ethical 
considerations that were taken into account when the study was conducted. 
 
3.1 STUDY DESIGN 
For the first part of the study a quasi-experimental design with a historically matched control 
group (Portney & Watkins, 2009) was used to determine the effect of the CPAx tool on patients’ 
clinical outcomes. Participants assessed with the CPAx tool were compared to carefully matched 
data (age, gender, admission diagnosis, severity of illness) of previous admissions into the same 
ICU.  A comparison was made with regards to ICU and hospital LOS between the groups.  
 
For the second part of the study, a survey-based design was used. A questionnaire was 
developed and used; quantitative data were collected to determine the perceptions and views of 
physiotherapists towards the use of the CPAx tool in clinical practice in the intensive care unit.  
 
3.2 SUBJECTS 
3.2.1 Sample Selection and Demographics 
Participants for the study (patients and physiotherapists) were selected from Chris Hani 
Baragwanath Academic hospital. This hospital is a tertiary institution in Soweto Johannesburg. 
The ICU has two floors with nine beds on each floor. The lower floor is reserved for patients with 
medical conditions or who underwent general surgical procedures and the second floor is 
reserved for admission of patients with traumatic injuries. There are four therapists that work in 
the ICU (two on each floor). Two therapists work permanently in the ICU and the other two rotate 
through different work areas on a quarterly basis. All four therapists have an additional workload 
outside the ICU in the medical and surgical wards. Subject recruitment started in October 2015 
and data collection was completed in February 2016.   
 
3.2.1.1 Inclusion criteria 
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All male and female patients admitted into the trauma ICU and surgical patients admitted into 
the general ICU were considered for inclusion in the first part of the study. 
 
All physiotherapists working in the trauma ICU and general ICU were considered for inclusion in 
the second part of the study. 
 
3.2.1.2 Exclusion criteria 
The following patients were excluded from participation in the first part of the study: 
 Patients who were bedridden prior to admission to ICU due to orthopaedic, neurological or 
neuromuscular conditions. 
 
 Patients placed on bed rest in ICU as a result of complex orthopaedic and/or spinal injuries 
sustained. 
 
 All patients admitted to the general ICU and trauma ICU one month prior to the start of the 
pilot study (clinicians familiarised themselves with the CPAx tool during this time). 
 
The following people were excluded from participation in the second part of the study: 
   
 Physiotherapists working in the paediatric ICU as the CPAx tool has only been validated for 
use in the adult ICU population to date. 
 
 Physiotherapy technicians and assistants as it is beyond their scope of practice to work in 
an ICU setting. 
 
3.2.2 Sample Size 
Patient admission information from the general ICU and trauma ICU was reviewed from 
December 2014 to February 2015 in order to calculate patients’ average ICU LOS. This 
information was used to calculate the sample size for the study. A sample size of 26 patients per 
group (width of C/I ± 3.7) was determined to yield 90% power to detect a difference of 12 hours 
in ICU and hospital LOS if a SD of 9.399 was used with alpha set at 5%, non-compliance at 10% 
and drop out (including mortality) at 38%.  
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3.2.3 Variables 
3.2.3.1 Independent variable 
The independent variable for the first part of the study was the CPAx score. 
 
3.2.3.2 Dependent variables 
The dependent variables for the first part of the study were:  
 ICU and hospital length of stay 
 APACHE II scores 
 SOFA scores 
 
3.3 STUDY PROCEDURES 
3.3.1  Instrumentation 
3.3.1.1 APACHE II score 
The APACHE II score (on-line calculator) was used to match injury severity and risk for mortality 
of participants in the experimental group with that of participants in the historical control group 
(Mica, et al., 2013; ClinCalc.com, 2015). The APACHE II has been shown to be a valid tool in 
predicting mortality in critically injured trauma patients when compared to other scoring systems 
(Dosset et al., 2009). The reliability of the APACHE II has been questioned as it has been shown 
to overestimate mortality risk (Polderman, et al., 2001). 
 
3.3.1.2 SOFA score 
The SOFA score (on-line calculator) was used to measure patients’ degree of organ dysfunction 
(Bale et al., 2013). The SOFA score has been shown to be an accurate and reliable measure 
(Arts, et al., 2005) as well as a good predictor of morbidity and mortality in critically ill patients 
(Ferreira, et al., 2001). Nair et al. (2016) found the SOFA score to be sensitive and specific. 
 
3.3.1.3 Hand-grip dynamometer 
A Smedley digital hand-grip dynamometer (Figure 3.1) was used to assess patients’ grip strength 
as required for the CPAx tool (Corner, et al., 2013). The dynamometer was obtained from Physio 
and Wellness Warehouse situated in Johannesburg, South Africa. 
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Figure 3.1: Smedley Digital Hand-Grip Dynamometer 
 
3.3.1.4 The Chelsea critical care physical assessment tool 
The CPAx tool was used to assess patients’ functional abilities and respiratory function (Corner, 
et al., 2014) (see Figure 3.2 and Appendix 1). A maximum score of 50 indicates normal functional 
ability and respiratory function and no physical morbidity. The CPAx tool has been shown to be 
a valid tool in the assessment of physical morbidity (Corner, et al., 2012) and has been proven 
to be effective in detecting changes in physical function (Corner, et al., 2015). The CPAx tool is 
also useful as it has a limited floor and ceiling effect (Corner, et al., 2015). Reliability testing has 
shown that CPAx has strong internal consistency and inter-rater reliability between five different 
testers (Corner, et al., 2013).  
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Figure 3.2:  Chelsea Critical Care Physical Assessment tool 
 
3.3.1.5 Individual Participant Record Sheets  
            These were used to capture demographic information, admission dates, discharge dates and 
other relevant information (Appendix 2).  
 
3.3.1.6 Questionnaire  
A questionnaire was developed in order to establish clinician’s perceptions towards the use of 
the CPAx tool. It was administered to all suitable physiotherapy clinicians who used the CPAx 
tool during the first part of the study (Appendix 3). The questionnaire was administered to 
physiotherapy clinicians in part two of this study. 
 
3.3.2 Data Collection Procedure 
 
3.3.2.1 Part one of the study 
3.3.2.1.1 Procedures prior to the pilot study 
All physiotherapy clinicians who work in the general ICU and trauma ICU of Chris Hani 
Baragwanath Academic hospital were required to complete the online CPAx training 
module (cpax.ocbmedia.com) developed by E. Corner. This training module had to be 
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completed by the clinicians before they were allowed to administer the CPAx tool to the 
study participants. The online programme issues a certificate if an individual successfully 
passes the training module. Clinicians were only allowed to participate in the study if they 
were able to produce their certificate of completion. Copies of the certificates have been 
kept by the researcher (Appendix 4). These physiotherapists acted as research 
assistants for the duration of the first part of the study. Following completion of the CPAx 
training module, the clinicians were given one month to familiarise themselves with using 
the tool during patient assessment and re-assessment in ICU in preparation for the pilot 
study and main study. The researcher gave advice to the research assistants during the 
pilot study when questions arose in order to ensure that they were comfortable using the 
tool. 
 
3.3.2.1.2 Pilot study 
A pilot study was performed on five participants in ICU. Five participants were selected 
as this equates to approximately ten percent of the total study population. The aim of the 
pilot study was to determine the inter-rater reliability of CPAx tool scores obtained 
between the research assistants for the pilot study participants. The two research 
assistants assessed the five participants together but decided on the patients’ CPAx 
scores separately. After completion of the pilot study, results obtained were analysed and 
discussed between the researcher and the study supervisor (view results of pilot study 
in Chapter 4). Good inter-rater reliability was demonstrated which meant that no changes 
were implemented for the data collection procedure of the main study. Data obtained 
from the five pilot study participants were included in the main study data set. Their CPAx 
scores were recorded as the sum of the two scores obtained by the research assistants 
divided by two.  
 
3.3.2.1.3 Main study 
Patients admitted to the general ICU as well as the trauma ICU were screened 
consecutively by the researcher and research assistants against the inclusion and 
exclusion criteria for the study, to determine their suitability for participation in the study. 
Once suitable participants were identified, the researcher approached the patients and 
explained the aims of the study to them to obtain informed consent (Appendix 5). 
Temporary informed consent forms were kept available in case the patients were not 
conscious or orientated in order for the researcher to approach the patients’ 
parents/spouses in the presence of the ICU nurse or ICU doctor (face-to-face or 
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telephonically) to explain the aims of the study to them to obtain temporary informed 
consent for their relative to be included in the study. The director/deputy director of critical 
care at Chris Hani Baragwanath Academic hospital was approached to obtain temporary 
consent in the event that the patient’s family could not be located or in the event that the 
patient’s identity could not be confirmed (Appendix 6). However, participants that were 
recruited into the CPAx (experimental) group were approached when they were 
orientated to person, place and time with a GCS of 10/10 or 15/15. This resulted in 
temporary consent from a caregiver or the director/deputy director of critical care not 
being required. 
 
Once informed consent was obtained, the researcher informed the research assistants 
of such. Research assistants were assigned patients according to the daily patient loads 
and logistics in the ICUs at the time of the study. No randomisation of participant 
allocation to research assistants took place. The research assistants assessed each 
participant according to the CPAx tool criteria (Appendix 1). Following this, the 
participants received their physiotherapy treatment daily (or bi-daily if required) according 
to problem areas identified with the CPAx tool. Treatment was provided by all 
physiotherapists working in the ICU. In other words, patient management was not 
restricted to the research assistants only. Treatment of study participants was given 
according to the plan laid out by the research assistants after CPAx assessments were 
performed. Subsequent assessments using CPAx tool were performed by the research 
assistants for all included participants every second weekday of their stay in ICU 
(Monday, Wednesday and Friday) and progression of treatment was performed 
according to the ongoing CPAx assessment findings. CPAx assessments were 
performed on alternate weekdays in order to mimic the study performed by Corner et al. 
(2014). In the above-mentioned study, participants were assessed at least three times 
per week using the CPAx tool. 
 
Data was captured on individual patient record sheets. Date and time was recorded for 
ICU/hospital admission and discharge. Following discharge from the ICU, the participants 
continued to receive physiotherapy in the ward as required but use of the CPAx tool was 
terminated at patient discharge from ICU.   
 
The researcher matched information of each included participant in the CPAx group to 
the ICU patient record data bases of the general and trauma ICUs in order to identify 
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suitable historical controls for the study. Intensive care unit charts were used to determine 
information of patients in both the historical control and CPAx (experimental) groups. 
Matching was performed according to the following criteria: 
 
 Age: Control participants were considered a potential match if they fell into the same 
age category as the participant recruited into the CPAx group. Age categories were 
defined as follows: a) 20-29 years, b) 30-39 years, c) 40-49 years, d) 50-59 years 
and e) 60-69 years. 
 
 Diagnosis: Surgical patients were matched according to the surgical procedure that 
they underwent (for example laparotomy). Trauma patients were matched according 
to the nature of injury (blunt versus penetrating) and as far as possible they were 
matched according to the types of injuries sustained as well as the surgical 
procedures that they underwent for management of injuries.  
 
 Gender: Male and female participants were matched accordingly. 
 
 APACHE II score: Historical control participants were considered a potential match if 
their APACHE II score was within three points of the APACHE II score for the 
participant recruited into the CPAx group. 
 
Participants were matched according to all four criteria mentioned above. The matching 
variables and processes performed were designed based on those used in a study by 
Beattie et al. (2012). Beattie et al. aimed to describe the population of patients who 
acquired ventilator-associated pneumonia (2012).  A retrospective case note review was 
conducted where cases were each matched with two controls (Beattie et al. 2012). Cases 
were matched according to age (within ten years), gender (male or female), APACHE II 
score (within five points) and number of ventilator days (Beattie et al. 2012). 
 
Patients admitted to the general and trauma ICUs in the month prior to the start of the 
pilot study were not considered for inclusion in the historical control group as clinicians 
would have been using the CPAx tool, for the purpose of familiarisation, already during 
this time which would have resulted in skewed data. Historical controls were selected 
from patients that were admitted into the ICUs during the period 1 January 2014 to 30 
June 2015. 
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The researcher entered information obtained into the on-line APACHE II calculator to 
determine risk for mortality for study participants in the CPAx group and for historical 
control participants. It is not standard practice for all patients to have APACHE II scores 
calculated on admission to the general or trauma ICU at Chris Hani Baragwanath 
Academic hospital, therefore APACHE II scores were calculated by the researcher and 
research assistants for subjects in both the CPAx and control groups. All information 
required was easily accessible on the ICU charts as well as from the database where 
blood results are stored. APACHE II scores for participants in the CPAx group were 
calculated on admission. APACHE II scores for the historical control group were 
calculated once historical patients were identified as potential matches for participants in 
the CPAx group. In other words, once it was established that the potential control 
participants matched the CPAx participants according to age, gender and diagnosis then 
admission information for these participants was used to calculate APACHE II scores 
thus determining if they were appropriate matches or not. The matching process used is 
reproducible. The results were documented on the individual patient record sheets 
designed for this study.  
 
The researcher also entered information obtained for participants in the CPAx group and 
for historical controls into the on-line SOFA calculator (re-assessed on alternate 
weekdays during their ICU stay) to determine risk for organ dysfunction and captured the 
results on the individual patient record sheets. The SOFA score was re-assessed for all 
study participants on every second weekday of their ICU stay and recorded accordingly 
(see Appendix 2).The on-line SOFA and APACHE II calculators were used during the 
period October 2015 to March 2016. The researcher tracked and recorded ICU LOS and 
hospital LOS for each participant in the CPAx and historical control groups.  
 
3.3.2.2 Part two of the study 
3.3.2.2.1 Procedures prior to the pilot study 
A questionnaire was drawn up by the researcher and her supervisor prior to the study. 
The aim of the questionnaire was to establish physiotherapists’ perceptions of the CPAx 
tool when used in a surgical and trauma patient population (Appendix 3). 
 
 
3.3.2.2.2 Main study 
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For the second part of the study, the researcher approached all physiotherapy clinicians 
that were involved in the first part of the study and gave them a printed copy of the 
questionnaire to complete in their own time (Appendix 3). A clearly labelled box was 
placed in the physiotherapy department of Chris Hani Baragwanath Academic hospital 
into which completed questionnaires were deposited.  
 
All information obtained during part one and part two of this study was entered by the 
researcher, in consultation with her supervisor, on Excel spreadsheets in preparation for 
data analysis.  
 
3.4 ETHICAL CONSIDERATIONS 
Ethical clearance for the study was obtained from the University of the Witwatersrand Human 
Research Ethics (Medical) Committee (Appendix 7). Permission was obtained from the Medical 
Advisory Committee, the Chief Executive Officer, the Director of Critical Care and the Assistant 
Director of Physiotherapy at Chris Hani Baragwanath Academic hospital to perform this study 
(Appendices 8, 9 and 10). A comprehensive information sheet was given to the 
patients/caregivers as well as the clinicians recruited (Appendices 11and 12) and written consent 
was obtained from the patients/caregivers prior to enrolment of participants into the first part of 
the study (Appendices 5 and 6). Participants were allowed to withdraw from the study at any 
time without any penalty to them or any consequences to their continued care while in hospital. 
All information obtained about study participants was coded to preserve the participants’ identity. 
A separate coding list was kept on which the participant’s name and allocated subject code was 
documented. This list was password protected and stored on the researcher’s computer. Any 
information obtained was used for statistical purposes only and no personal information was 
disclosed about the patients. This study was registered with the South African National Clinical 
Trials Registry through the Department of Health (trial registration number: DOH-27-0816-5496). 
 
3.5 STATISTICAL ANALYSIS 
 
3.5.1 Part one of the study: 
The data obtained was nominal and interval in nature. Data was captured on an Excel 
spreadsheet. The IBM® Statistical Package for Social Sciences (SPSS) version 24 for Windows 
was utilized to analyse data collected. Descriptive statistics were used to present the data. 
Categorical data were summarized as frequencies and percentages in the text as well as in 
illustrative tables or pie charts. Continuous data were presented as means and standard 
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deviations (SD) in the text as well as in tables and graphs. Comparisons of ICU and hospital 
LOS between the study participants and historical control group were done using an independent 
t-test.  Pearson’s correlation coefficient was used to determine if an association existed between 
CPAx scores, APACHE II scores or SOFA scores. A p-value ≤ 0.05 was deemed statistically 
significant.  
 
3.5.2 Part two of the study: 
The data obtained in the second part of the study was descriptive in nature. Results were 
reported in narrative form. 
 
  
28 
 
 
CHAPTER 4 
 
4. RESULTS 
Results for phase one of this study are reported in the format of the Transparent Reporting of 
Evaluations with Nonrandomised Designs (TREND) statement for nonrandomised experimental 
trials. Results for phase two of the study are reported in narrative form towards the end of this 
chapter. 
 
4.1 PART ONE OF THE STUDY: INTER-RATER RELIABILITY BETWEEN RESEARCH 
ASSISTANTS 
The pilot study was performed on two research assistants and five participants, three of which 
were participants who underwent surgical procedures and two were participants with traumatic 
injuries. 
 
The data for the CPAx tool is continuous in nature. Therefore in order to determine inter-rater 
reliability for the CPAx tool between the two raters, the intra-class correlation coefficient (ICC) 
was calculated. The results showed ICC = 0.999 (95% confidence intervals (CI) = 0.994-1). This 
demonstrated excellent inter-rater reliability between the two raters. In 95% of cases the inter-
rater reliability between these two raters was therefore likely to fall between 0.994 and 1.  
 
4.2. STUDY POPULATION FOR PART ONE STUDY 
The number of patients admitted into the two ICUs during the period 19 October 2015 to 29 
February 2016 and the recruitment of participants to the study is summarised in the flow diagram 
in Figure 4.1. During the study period 30 participants were recruited into the CPAx group. Four 
participants were excluded from this group as the researcher was unable to find appropriate 
historical control matches for them. One participant in the CPAx group died during his stay in the 
ICU.  
 
Twenty six participants were recruited into the historical control group. Two participants died in 
the wards following their discharge from the ICU and one was transferred to another hospital 
following his discharge from the ICU.  
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Figure 4.1: Summary of Patient Recruitment for the Study 
 
 
4.2.1 Baseline Characteristics of the Study Population 
4.2.1.1 Age 
The mean age for the CPAx group was 37.88 (±13.37) years with the minimum age being 21 
years and the maximum age being 68 years. The mean age for the control group was 37.81 
(±12.21) years with the minimum being 21 years and the maximum being 66 years. There was 
Historical Control Group
n=26
CPAx (Experimental) Group
Total poulation in ICU
n=299
Trauma (n=131)
Medical and surgical 
(n=168)
Included
n=30
n=26
Unable to find suitable matches (n=4)
Excluded (n=269)
- Medical patients that didn't undergo surgical 
procedures (n=101)
- Patients that are not suitable or not stable 
for physiotherapy (n=25)
- Trauma patients on bed rest (n=54)
- Those admitted and discharged over the    
weekend (n=89)
30 
 
no statistically significant difference in age between the two groups (p=0.7) which shows that the 
groups were well matched. 
 
4.2.1.2 Gender 
The patient population consisted of 65.4% (n=34) male and 34.6% (n=18) female participants. 
The CPAx group consisted of 17 (65.4%) male participants and nine (34.6%) female participants 
(Figure 4.2). The control group consisted of 17 (65.4%) male participants and nine (34.6%) 
female participants (Figure 4.3). There was no difference in gender between the two groups 
(p=1). 
 
 
Figure 4.2: Gender Distribution of                    Figure 4.3: Gender Distribution of  
            CPAx Group                                                                   Control Group 
 
4.2.1.3 Severity of illness on admission (APACHE II score) 
The mean APACHE II score for the CPAx group was 11.58 (±5.16) with a minimum score of 2 
points and a maximum score of 24 points. The mean APACHE II score for the control group was 
11.96 (±4.99) with a minimum score of 2 points and a maximum score of 21 points. There was 
no statistically significant difference in APACHE II scores (p=0.81) between the two groups which 
shows that the groups were well matched. 
 
4.2.1.4 Diagnosis 
The patient population consisted of 28 (53.8%) participants who underwent surgical procedures 
and 24 (46.2%) participants with traumatic injuries. The CPAx group consisted of 14 (53.8%) 
participants who underwent surgical procedures and 12 (46.2%) participants with traumatic 
injuries. The control group consisted of 14 (53.8%) participants who underwent surgical 
Gender
Male Female
Gender
Male Female
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procedures and 12 (46.2%) participants with traumatic injuries. There was no difference in 
diagnosis between the two groups (p=1). 
 
Five participants from the CPAx group sustained more than one traumatic injury whereas seven 
sustained single traumatic injuries. Eleven of the 12 participants with traumatic injuries in the 
CPAx group sustained penetrating injuries whereas only one participant sustained blunt trauma. 
The specific trauma and surgical diagnoses are listed in Table 4.1below. 
 
Table 4.1: Diagnoses of participants in the experimental group 
ID Diagnosis 1  Diagnosis 2 Trauma/Surgical 
1 Caesarean section   Surgical 
2 Sternotomy Flexor tendon injury Trauma 
3 Thoracotomy   Trauma 
4 Head and neck extensive surgery   Surgical 
5 Head and neck extensive surgery   Surgical 
6 Exploratory laparotomy for gunshot wound   Trauma 
7 Exploratory laparotomy for gunshot wound   Trauma 
8 Neck exploration   Trauma 
9 Thoracotomy Sternotomy Trauma 
10 Clavicle fracture Rib fractures Trauma 
11 Exploratory laparotomy for gunshot wound Ulna fracture Trauma 
12 Exploratory laparotomy for gunshot wound   Trauma 
13 Exploratory laparotomy for gunshot wound   Trauma 
14 Neck exploration Sternotomy Trauma 
15 Multiple stab wounds   Trauma 
16 Laparotomy for adrenal mass resection   Surgical 
17 Caesarean section   Surgical 
18 Debridement for necrotising fasciitis   Surgical 
19 Caesarean section   Surgical 
20 Caesarean section   Surgical 
21 Nephrectomy   Surgical 
22 Laparotomy for total colectomy   Surgical 
23 Whipples procedure   Surgical 
24 Caesarean section   Surgical 
25 Laparotomy for complicated appendicectomy   Surgical 
26 Caesarean section   Surgical 
 
Four participants from the historical control group sustained more than one traumatic injury 
whereas eight sustained single traumatic injuries. Eleven of the 12 participants with traumatic 
injuries in the control group sustained penetrating injuries whereas only one participant sustained 
blunt trauma. The specific trauma and surgical diagnoses are listed in Table 4.2 below. 
 
 
Table 4.2: Diagnoses of participants in the control group 
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ID Diagnosis 1  Diagnosis 2 Trauma/Surgical 
50 Caesarean section   Surgical 
51 Sternotomy Flexor tendon injury Trauma 
52 Thoracotomy   Trauma 
53 Head and neck extensive surgery   Surgical 
54 Head and neck extensive surgery   Surgical 
55 Exploratory laparotomy for gunshot wound   Trauma 
56 Exploratory laparotomy for gunshot wound   Trauma 
57 Neck exploration   Trauma 
58 Sternotomy  Trauma 
59 Tibia-fibular fracture (ORIF done) Rib fractures Trauma 
60 Exploratory laparotomy for gunshot wound 
Gunshot wound to 
the face Trauma 
61 Exploratory laparotomy for gunshot wound   Trauma 
62 Exploratory laparotomy for gunshot wound   Trauma 
63 Neck exploration Sternotomy Trauma 
64 Multiple stab wounds   Trauma 
65 
Laparotomy for tumour removal 
(pancreatic cancer)   Surgical 
66 Caesarean section   Surgical 
67 Debridement for necrotising fasciitis   Surgical 
68 Caesarean section   Surgical 
69 Caesarean section   Surgical 
70 Nephrectomy   Surgical 
71 Laparotomy for bowel disease   Surgical 
72 Whipples procedure   Surgical 
73 Caesarean section   Surgical 
74 Laparotomy for bowel disease   Surgical 
75 Caesarean section   Surgical 
 
 
4.2.1.5 Initial extent of organ dysfunction (SOFA score) 
The mean initial SOFA score for the CPAx group was 2.42 (±1.79) with a minimum score of 0 
points and a maximum score of 8 points. The mean initial SOFA score for the control group was 
4.15 (±2.6) with a minimum score of 0 points and a maximum score of 11 points. A p=0.03 
(Mann-Whitney test: p=0.01) indicates that there was a statistically significant difference 
between the two groups with regards to initial SOFA scores. This suggests that the historical 
control group had a higher degree of organ dysfunction at the start of the trial when compared 
to the CPAx group. 
 
4.2.1.6 Extent of organ dysfunction at ICU discharge (SOFA score) 
There were 25 participants who had SOFA scores measured at ICU discharge (10 participants 
in the CPAx group and 15 participants in the control group). Only 25 SOFA scores were available 
at ICU discharge for the whole study population because some patients only had one SOFA 
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score calculated during their ICU stay. In the above-mentioned cases, the score was recorded 
as the ‘initial SOFA score’ and these participants did not have a SOFA score measured or 
recorded at ICU discharge. 
 
The mean SOFA score at ICU discharge for the CPAx group was 1.80 (±0.42) with a minimum 
score of 1 point and a maximum score of 2 points. The mean SOFA score at ICU discharge for 
the historical control group was 2.87 (±1.81) with a minimum score of 1 point and a maximum 
score of 8 points. A p=0.05 (Mann-Whitney test: p=0.05) indicates that there was a statistically 
significant difference between the two groups with regards to SOFA scores at ICU discharge. 
This suggests that the control group had a higher degree of organ dysfunction at ICU discharge 
when compared to the CPAx group (Figure 4.4). 
 
 
 
Figure 4.4: Graph Depicting the Initial SOFA Scores and SOFA Scores at ICU Discharge 
of CPAx Group and Control Group  
 
 
 
 
4.2.2 Clinical Outcomes 
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4.2.2.1 ICU length of stay 
 
The mean ICU LOS for the CPAx group was 5.84 days (±7.43) with a minimum 0.79 days and a 
maximum of 34.21 days. The mean ICU LOS for the control group was 4.56 days (±5.25) with a 
minimum of 0.58 days and a maximum score of 21.08 days. Although the CPAx group had a 
greater mean ICU LOS than the historical control group, a p=0.54 (Mann-Whitney U test: p=0.27) 
suggests that there was no statistically significant difference in ICU LOS between the two groups.  
 
4.2.2.2 Hospital length of stay 
One participant from the CPAx group died during his stay in ICU which means that there was 
hospital LOS data for 25 of the 26 participants initially recruited into the CPAx group. Two 
participants from the historical control group died during their hospital stay and one was 
transferred to another hospital following his discharge from the ICU. This means that hospital 
LOS was measured for 23 of the 26 participants initially recruited into the historical control group.  
 
The mean hospital LOS for the CPAx group was 17.43 (±16.68) days with a minimum of 4.71 
days and a maximum of 79.13 days. The mean hospital LOS for the control group was 19.31 
days (±5.79) with a minimum of 5.08 days and a maximum score of 59.71 days. Although the 
historical control group had a greater mean hospital LOS than the CPAx group, a p=0.80 (Mann-
Whitney test: p=0.42) suggests that there was no statistically significant difference between the 
two groups. 
 
4.2.2.3 Physical morbidity (CPAx scores) 
CPAx scores were measured for participants in the CPAx group on alternate days during the 
patients’ ICU LOS. One participant died during his stay in the ICU. If participants only had two 
CPAx scores taken during their stay in the ICU, then these scores were recorded as ‘initial CPAx 
score’ and ‘CPAx score at discharge’ respectively. There were 26 initial CPAx scores measured, 
four CPAx scores measured at midway and 10 CPAx scores measured at discharge from the 
ICU. Only 10 CPAx scores were available at ICU discharge because some patients only received 
one CPAx assessment during their ICU stay. In the above-mentioned cases, the score was 
recorded as the ‘initial CPAx score’ and these participants did not have a CPAx score measured 
or recorded at ICU discharge. Any participants that received three or more CPAx scores would 
have had a midway score recorded. 
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The mean initial CPAx score for the CPAx group was 29.73 points (±14.81) with a minimum 
score of 2 points and a maximum score of 49 points. The mean midway CPAx score was 10.75 
(±14.36) with a minimum score of 2 points and a maximum score of 32 points. The mean CPAx 
score at ICU discharge was 36.15 (±8.33) with a minimum score of 23 points and a maximum 
score of 46 points. The mean difference in CPAx scores between ICU admission and ICU 
discharge was 6.42 for the CPAx group. 
 
The mean initial CPAx score for all participants who underwent surgical procedures was 32.75 
(±14.16) with a minimum score of 2 points and a maximum score of 46 points. The mean initial 
CPAx score for all participants with traumatic injuries was 26.21 (±15.39) with a minimum score 
of 23 points and a maximum score of 39.5 points. The difference in mean CPAx scores on ICU 
admission between participants who sustained traumatic injuries and those who underwent 
surgical procedures was 6.54.A p=0.27 (Mann-Whitney test: p=0.35) indicates that there was no 
statistically significant difference in initial CPAx scores between the surgical and trauma 
participants. 
 
There were 10 participants who had CPAx scores measured at ICU discharge. Five participants 
(50%) were trauma cases and five participants (50%) were surgical cases. The mean CPAx 
score at ICU discharge for all participants who underwent surgical procedures was 42.20 (±4.09) 
with a minimum score of 7 points and a maximum score of 49 points. The mean CPAx score at 
ICU discharge for all participants with traumatic injuries was 30.10 (±6.91) with a minimum score 
of 23 points and a maximum score of 39.5 points. The difference in mean CPAx scores at ICU 
discharge between participants who sustained traumatic injuries and those who underwent 
surgical procedures was 12.10 .A p=0.01 (Mann-Whitney test: p=0.03) indicates that there was 
a statistically significant difference in CPAx scores at ICU discharge between the surgical and 
trauma participants (Figure 4.5). 
 
The mean CPAx scores for participants who underwent surgical procedures changed by 9.45 
points between admission and discharge from ICU. The mean CPAx scores for participants who 
sustained traumatic injuries changed by 3.9 points between admission and discharge from ICU. 
From this it can be postulated that the CPAx tool is more useful to detect change in physical 
function in surgical participants than in participants with traumatic injury. 
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Figure 4.5: Figure Depicting the Difference in CPAx Scores at ICU Discharge between 
Participants with Different Admission Diagnoses 
 
4.2.2.4 Association between severity of illness and physical morbidity scores on admission into 
the ICU 
A Pearson correlation coefficient was computed in order to determine the association between 
APACHE II scores and initial CPAx scores for subjects in the CPAx group (n=26). Results 
indicated that APACHE II scores had a very weak negative correlation with initial CPAx scores 
(r=-0.07). This association was not statistically significant (p=0.74).  
 
4.2.2.5 Association between severity of illness and physical morbidity scores at ICU discharge 
A Pearson correlation coefficient was computed in order to determine the association between 
APACHE II scores and CPAx scores at ICU discharge for subjects in the CPAx group (n=10). 
Results indicated that APACHE II scores had a very weak positive correlation with CPAx scores 
at ICU discharge (r=0.06). This finding was not statistically significant (p=0.87).  
 
4.2.2.6 Association between extent of organ dysfunction and physical morbidity scores on 
admission into the ICU 
A Pearson correlation coefficient was computed in order to determine the association between 
initial SOFA scores and initial CPAx scores for subjects in the CPAx group (n=26). Results 
indicated that initial SOFA scores had a moderate negative correlation with initial CPAx scores 
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(r=-0.45) (Figure 4.6). This suggests that a smaller extent of organ dysfunction on admission to 
ICU may result in a reduction in physical morbidity as a higher initial CPAx score indicates better 
physical function. The results were statistically significant (p=0.02).  
 
 
Figure 4.6: Graph Depicting the Relationship between Extent of Organ Dysfunction and 
Physical Morbidity Scores on Admission into the ICU 
 
4.2.2.7 Association between extent of organ dysfunction on admission and physical morbidity at 
ICU discharge 
A Pearson correlation coefficient was computed in order to determine the association between 
initial SOFA scores and CPAx scores at ICU discharge for the CPAx group (n=10). Results 
indicated that initial SOFA scores had a weak negative correlation with CPAx scores at ICU 
discharge (r=-0.24). The results were not statistically significant (p=0.51).  
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4.2.2.8 Association between physical morbidity at admission and extent of organ dysfunction at 
ICU discharge 
A Pearson correlation coefficient was computed in order to determine the association between 
initial CPAx scores and SOFA scores at ICU discharge for the CPAx group (n=10). Results 
indicated that initial CPAx scores had a moderate positive correlation with SOFA scores at ICU 
discharge (r=0.47). The results were not statistically significant (p=0.17).  
 
4.2.2.9 Association between physical morbidity at ICU discharge and extent of organ dysfunction 
at ICU discharge 
A Pearson correlation coefficient was computed in order to determine the association between 
CPAx scores at ICU discharge and SOFA scores at ICU discharge for the CPAx group (n=10). 
Results indicated that CPAx scores at ICU discharge had a very strong positive correlation with 
SOFA scores at ICU discharge (r=0.80) (Figure 4.7). This suggests that as the extent of organ 
dysfunction increases, a reduction in physical morbidity may be observed (higher CPAx scores 
represent less physical morbidity). The results were statistically significant (p=0.05). Similar 
results were found when doing the Spearman correlation test (r=0.70, n=10, p=0.03).  
 
 
Figure 4.7: Graph Depicting the Relationship between Physical Morbidity at ICU 
Discharge and Extent of Organ Dysfunction at ICU Discharge 
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4.3 PART TWO OF THE STUDY: PHYSIOTHERAPISTS’ PERCEPTIONS OF THE CPAX TOOL 
 
All clinicians who were working in the ICU during the data collection period were considered for 
recruitment into the study. There were five clinicians (other than the researcher) working in the 
ICU at the time; all of which volunteered to participate in the study. Due to logistical reasons, 
three of the clinicians were excluded from the study. This allowed them to take care of the other 
patients in the ICU that were not recruited into the study and assist with the workload in other 
areas. Two clinicians were therefore recruited into the study. Please see Figure 4.8 below. 
 
 
Figure 4.8: Summary of Clinician Recruitment for the Study 
 
Two research assistants were recruited into the study to assist with data collection for 
participants in the CPAx group. They completed questionnaires to assess their perceptions of 
the CPAx tool. The results are as follows: 
 
Physiotherapy Clinicians working in ICU
Total population of clinicians working 
in ICU
n=4
Included
n=2
Total excluded (n=2)
- Clinicians rotating into other areas during the predicted data 
collection period (n=2)
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4.3.1 Demographics of Participants 
Both research assistants had undergraduate (Bachelor of Science in Physiotherapy) 
qualifications and the preferred area of clinical work for both was in cardiopulmonary/ICU 
settings. Both had less than five years’ experience working as a physiotherapist. The first 
clinician had more than three years of experience working in the ICU setting whereas the second 
clinician had less than three years of work experience in ICU. The first clinician worked between 
11 and 15 hours per week in the ICU and had an average patient load in the ICU of four to six 
patients whereas the second clinician worked between five and 10 hours per week in the ICU 
and had a patient load in the ICU of seven to nine patients. Both had a daily average patient 
load of more than nine patients outside of the ICU. The first clinician reported to the occasional 
use of outcome measures to assess patients’ responses to treatment; however, the second 
clinician reported infrequent use of outcome measures.  
 
4.3.2 Use of the CPAx Tool 
Neither clinician had ever heard of the CPAx tool prior to the start of this study nor were they 
aware of any other tool that measured physical morbidity in the ICU. Neither clinician answered 
the question asking to give further comments if they prefer not to use outcome measures in their 
daily clinical practice. 
 
4.3.3 Perceptions of Participants regarding the CPAx Tool 
Both clinicians found that the CPAx tool enhanced their accuracy of patient assessment. The 
first clinician agreed that the CPAx tool was not appropriate when used with patients with certain 
admission diagnoses (especially patients with multiple traumatic injuries) whereas the second 
clinician did not agree with this statement. Both clinicians felt that the tool assisted with patient 
care and planning, evaluating patient progression, motivating patients to partake in treatment, 
enhancing communication with patients as well as motivating physiotherapists regarding patient 
treatment.  
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The clinicians both agreed that the tool was not time consuming to use or difficult to interpret. 
They also established that the tool did not consist of variables that were difficult to interpret and 
did not require too much effort than proved necessary. The statement “did not require too much 
effort than proved necessary” suggests that effort taken to administer the tool was worth the time 
it took to administer it. Both clinicians agreed that the CPAx tool was comprehensive enough to 
be administered independently. The term "comprehensive enough to be administered 
independently" suggests that the CPAx tool assesses all areas necessary to complete a 
thorough functional assessment of the patients.  
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CHAPTER 5 
 
5. DISCUSSION 
This chapter involves interpretation of the results laid out in the previous chapter. The challenges 
and limitations of the study are also discussed here. 
 
This study is the first in South Africa to assess the effects of the CPAx tool on patient outcomes 
in a critical care setting and to assess physiotherapists’ perceptions about the CPAx tool. 
Participants in the CPAx and historical control groups were well matched with regards to age, 
gender, admission diagnosis and APACHE II scores. It is important to note that participants in 
the control group had a statistically significant higher mean SOFA score on admission and at 
discharge from the ICU when compared with those in the CPAx group. This suggests that 
historical control participants had a larger extent of organ dysfunction and risk for mortality on 
admission into the unit as well as on discharge from the unit when compared with participants in 
the CPAx group. 
 
5.1 THE EFFECT OF THE USE OF THE CPAX TOOL ON LENGTH OF STAY IN ICU AND IN THE 
HOSPITAL IN THE CARE OF CRITICALLY ILL PATIENTS 
 
It was assumed that the use of the CPAx tool for objective assessment of patients’ functional 
abilities during ICU stay would result in more goal-directed physiotherapy patient management 
resulting in changes in ICU and hospital LOS. A recent survey of physiotherapy practice in South 
African ICUs showed that majority of respondents used exercise therapy and out-of-bed 
mobilisation as part of their daily management of patients in ICU (Lottering & Van Aswegen, 
2016). Intensive care unit LOS and hospital LOS were measured in this study as these are 
outcomes that have been assessed in many other studies based on early rehabilitation strategies 
(Morris et al., 2008; Engel et al., 2009; Malkoc et al.,2009). Results from three studies showed 
that patients in the experimental groups who received physiotherapy that included early 
mobilisation strategies had a significantly shorter LOS in the ICU or in the hospital (Morris et al., 
2008; Engel et al., 2009; Malkoc et al., 2009). 
 
Results of the current study showed that the mean ICU LOS for participants in the CPAx group 
was 5.84 days and the control group was 4.56 days. Corner et al. investigated the relationship 
between CPAx scores and hospital discharge location (Corner et al., 2014). The authors found 
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that the mean ICU LOS of their whole study population was 11.54 days (Corner et al., 2014). 
This study took place in an ICU in the United Kingdom (Corner et al., 2014). All participants 
recruited into their study received CPAx assessments and the target was a minimum of three 
CPAx assessments per week (Corner et al., 2014). A similar frequency of CPAx assessment 
was performed in the current study. The patient population recruited into the study by Corner et 
al (2014) was a mixed medical and surgical population whereas the current study had a mixed 
trauma and surgical population. This may account for the differences in ICU LOS between 
Corner et al.’s (2014) study and this study. 
 
It also appears that the ICU at Chris Hani Baragwanath Academic hospital in South Africa has a 
very high turnover of patients at any given time when comparing ICU LOS data for the CPAx 
group and the historical control group for this study to that described by Corner et al. (2014). 
There is a constant demand for ICU beds at Chris Hani Baragwanath Academic hospital which 
often leads to patients being discharged to the wards when they are still ill and would otherwise 
still require critical care if there were more beds available. This may offer another explanation 
for the differences in ICU LOS reported for this study and that of Corner et al. (2014). 
 
At the start of the current study it was hypothesised that participants in the historical control 
group would have a longer mean ICU LOS than those in the CPAx group as participants in the 
CPAx group might have received more goal-directed physiotherapy interventions.  On 
completion of the study, it was however established that the CPAx group had a longer mean ICU 
LOS than the historical control group but this finding was not statistically significant. The 
difference in ICU LOS cannot be attributed to the patients’ risk for morbidity and mortality on 
admission into the ICU as the groups had similar APACHE II scores and the historical control 
group had higher initial SOFA scores than the CPAx group. A possible explanation could be the 
fact that one participant in the CPAx group had an extended LOS in the ICU (34.21 days) 
whereas the maximum LOS for participants in the control group was only 21.08 days. Another 
contributing factor may be the reduction in sample size by the time of ICU discharge in this study.  
 
It was also hypothesised that participants in the control group would have a longer mean hospital 
LOS than those in the CPAx group. Results confirmed that participants in the control group had 
a longer mean hospital LOS than those in the CPAx group; however, the difference in hospital 
LOS was not statistically significant. Participants in the CPAx group had lower degrees of organ 
dysfunction than those in the control group which might account for their shorter period of 
hospitalisation. It is possible that the CPAx group had a shorter hospital LOS due to the fact that 
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the participants were more functional when they were discharged from ICU as a result of the 
goal-directed physiotherapy treatment that they received in ICU. This may have resulted in these 
participants spending less time in the ward than the historical control group participants resulting 
in a shorter hospital LOS. 
 
It is important to note that although early mobilisation of critically ill patients can improve other 
functional outcomes such as bed mobility, exercise tolerance and muscle strength (Stiller, 2013), 
unfortunate circumstances such as wound sepsis and multi-organ dysfunction may occur 
regardless of whether the patient was mobilised early or not. This patient population consisted 
of critically ill individuals who might have spent prolonged periods of time in the ICU and in the 
hospital for reasons that could not be influenced by physiotherapy interventions. 
 
5.2 THE USEFULNESS OF THE CPAX TOOL ACCORDING TO PATIENT ADMISSION 
DIAGNOSIS 
 
It is interesting to note that the mean midway CPAx scores were lower than the mean initial 
CPAx scores. One would expect the midway scores to be higher than the initial scores. A 
possible explanation is the fact that only four midway scores were recorded (due to patient 
discharge from ICU as explained in Chapter 4) whereas 26 initial CPAx scores were 
documented. 
 
In this study, participants who underwent a surgical procedure had a greater change in CPAx 
scores from ICU admission to ICU discharge when compared to change in CPAx scores in 
participants who had sustained traumatic orthopaedic injuries. From this it would appear that the 
CPAx tool is more useful to detect changes in physical morbidity/physical function in surgical 
populations than in trauma populations. 
 
Corner et al. (2015) found that CPAx was responsive to change from ICU admission until hospital 
discharge in patients who had sustained burn injuries. Patients with burn injuries are comparable 
to patients who undergo surgical procedures and therefore the results from the current study 
seem to support the usefulness of the CPAx tool as reported by these authors.  
 
Corner et al (2015) also discussed the fact that a change in CPAx score of six or more can be 
considered a clinically relevant change in physical function in a burns ICU population. One could 
hypothesise that in the current study, the mean difference in CPAx scores observed from ICU 
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admission to ICU discharge in the surgical group suggests a clinically relevant finding. This 
suggests that the surgical participants were more functional at discharge from the ICU than they 
were on admission into the unit; however, the current study was not performed in a burns cohort. 
 
Traumatic injuries in a South African context are often severe and consist of a combination of 
pedestrian-and-motor-vehicle accidents, interpersonal violence including penetrating and blunt 
trauma (Norman et al., 2007) as well as burn injuries. Norman et al. (2007) described the 
exceptionally high burden from injuries related to violence and road traffic injuries in South Africa. 
It is easy to hypothesise that patients (in a South African context) who have sustained multiple 
traumatic injuries may find it more difficult to mobilise while they are being cared for in the ICU. 
Although patients who sustained unstable pelvic or vertebral fractures were excluded from the 
study, there were five participants who had sustained more than one traumatic injury. One could 
hypothesise that multiple injuries would involve higher levels of pain experienced by patients and 
thus more difficulty to perform physical activities. Patients with multiple injuries may find it more 
difficult to progress with functional activities in which case the CPAx tool may be deemed less 
appropriate or effective to detect changes in physical function in these instances.  
 
 
5.3 THE RELATIONSHIP BETWEEN PHYSICAL MORBIDITY AND DISEASE SEVERITY 
Corner et al. (2014) found an association between age, APACHE II score and ICU LOS with 
discharge location; however, the authors did not investigate the relationship between APACHE 
II scores and CPAx scores.  
 
In this study, the CPAx scores for participants on admission into ICU demonstrated a weak 
inverse association with APACHE II scores. This inverse association can be interpreted by the 
fact that patients with a higher risk for mortality on admission into the ICU would have lower 
functional abilities and in turn lower CPAx scores measured. This was an expected finding even 
though it was not statistically significant.  
 
The CPAx scores on discharge from the ICU had a weak linear association with APACHE II 
scores on admission into the ICU. This suggests that patients with higher APACHE II scores on 
admission may have higher physical function scores on discharge from the ICU. One would 
expect that all CPAx scores would have a negative correlation with APACHE II scores and 
therefore this finding was unexpected. A possible explanation for this finding could be the low 
number of CPAx scores available at ICU discharge which might have skewed the results. 
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5.4 THE RELATIONSHIP BETWEEN PHYSICAL FUNCTION AND EXTENT OF ORGAN     
DYSFUNCTION 
 
Corner et al. (2013) found that CPAx had a significant negative correlation with SOFA scores in 
her mixed cohort of 33 general and trauma participants. Similar results emerged in this study 
where a statistically significant inverse association of moderate strength was found between 
initial SOFA scores and initial CPAx scores as well as a weak inverse association between initial 
SOFA scores and CPAx scores at ICU discharge. This negative association shows that 
participants with a higher degree of organ dysfunction on admission into the ICU would have 
lower functional abilities and in turn lower initial CPAx scores measured on admission. Similarly, 
the participants with higher SOFA scores on admission are more likely to have lower CPAx 
scores on discharge from the ICU as a result of higher degree of injury severity; although in this 
study there was a weak association between these variables at the time of ICU discharge. This 
can be explained by the relatively low number of CPAx scores available for data analysis at ICU 
discharge. 
 
When comparing initial CPAx scores with SOFA scores at discharge from the ICU, a moderate 
positive relationship between the two variables was established. Similarly when CPAx scores at 
ICU discharge were compared with SOFA scores at ICU discharge, a statistically significant 
positive association was found. This finding was unexpected and a possible explanation could 
be the small sample size at ICU discharge (only 10 participants had CPAx scores and SOFA 
scores measured at ICU discharge). A larger cohort of patients may be necessary in order to 
further investigate the association between CPAx scores and SOFA scores. 
 
5.5 PHYSIOTHERAPISTS’ PERCEPTIONS AND VIEWS OF THE USEFULNESS OF THE CPAX 
TOOL 
 
Corner et al. (2013) reported that CPAx was endorsed by physiotherapists that have reviewed 
and used the tool in a clinical setting. The current study also showed that clinicians supported 
the use of the tool. It is encouraging that both clinicians involved in this study had positive 
perceptions towards the use of the CPAx tool. This is important due to the fact that in the past, 
outcome measures in general have been described as time consuming and high in equipment 
requirements (Maher & Williams, 2005). Due to lack of funds in the South African public health 
care sector, outcome measures such as CPAx that require minimal equipment, may be useful in 
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the ICU setting. The tool also demonstrated good inter-rater reliability in spite of the small sample 
size used in the pilot study. This is in line with the good inter-rater reliability that was established 
by Corner et al. (2013) in their proof-of-concept pilot study. 
 
It should be noted that both clinicians verbally reported to the researcher that the tool was quick 
and easy to administer. They also reported that the respiratory domain is a factor that makes the 
CPAx tool unique when comparing it to other functional outcome measures (Corner et al., 2013). 
The views from these two participants may however be biased as they could have influenced 
each other’s ideas about the tool seeing that they worked together in the two ICUs in which the 
study was conducted. Therefore these findings should not be generalised but confirmed or 
refuted in future trials.  
 
5.6 CHALLENGES ENCOUNTERED AND LIMITATIONS TO THE STUDY 
 
5.6.1 Recruiting Participants into the CPAx Group 
Although there were 299 admissions in total into the trauma and general ICUs during the period 
of 19 October 2015 to 29 February 2016, many participants did not meet the inclusion criteria. 
Secondly, some participants were admitted and discharged over weekends which meant they 
were not considered for recruitment into the study.  
 
Due to long surgical waiting lists, many trauma patients were placed on bed rest while waiting 
for open reduction and internal fixation of their fractures. As these patients could not be mobilised 
due to unstable fractures, they could not be recruited into the study. Had these fractures been 
surgically stabilised immediately on admission to ICU, there would have been an opportunity to 
recruit these patients into the CPAx group.  
 
5.6.2 Matching Participants in the Historical Control Group with Those Recruited into the CPAx 
Group 
 
The researcher underestimated the difficulty required to appropriately match control participants 
with those in the CPAx group. The first problem encountered was matching according to 
diagnosis. Surgical patients were matched according to the surgical procedure that was 
performed. This was fairly straightforward in the case where the patients underwent a standard 
laparotomy or vascular procedure. However, unique or uncommon surgical procedures were a 
lot more difficult to match. Patients with traumatic injury were matched according to the injuries 
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sustained. This was challenging due to the wide variety of traumatic injuries that can be 
sustained in an assault situation or a motor vehicle accident.  
 
The second problem encountered was matching according to APACHE II scores. It was very 
difficult to match these scores within three points and this was often as a result of the GCS score 
on admission. Participants who had a low GCS on admission had very high APACHE II scores 
when compared to participants of the same age and diagnosis with a higher GCS on admission. 
In a trial performed by Beattie et al. (2012) which described a population of people who acquired 
VAP bundles, APACHE II scores were also utilised to match the participants between the two 
groups. Beattie et al. (2012) accepted APACHE II scores within five points as an acceptable 
match whereas in the current study, cases were matched according to APACHE II scores within 
a range of three points. By matching the participants within a range of three points instead of 
five points, it can be suggested that participants in the two groups in the current study were more 
closely matched for mortality risk when compared with the groups in the study by Beattie et al. 
(2012).  
 
Although participants in both groups were matched according to age, gender, diagnosis and 
APACHE II scores, the statistically significant difference in SOFA scores between the two groups 
indicated that participants in the two groups had different baseline characteristics with regards 
to the extent of organ dysfunction. This may have influenced the outcomes of the study. When 
performing future studies of a similar nature, it may be worth considering matching the patients 
according to initial SOFA scores as well as the other baseline variables mentioned above. The 
number of complications that participants developed during their ICU stay was not recorded or 
taken into account. This may have impacted on the matching process and may explain why the 
historical control group participants had higher degrees of organ dysfunction than the CPAx 
group participants. 
 
5.6.3 Sample Size 
Even though the proposed sample size for the study was achieved, it was a small sample size 
in total which gave the researcher limited power to detect differences in clinical outcomes 
between the two groups. A sample size calculation based on the effect of the CPAx tool on 
patient LOS of for example 24 hours instead of 12 hours (as used in this study), may yield a 
larger study sample at the same level of power (90%) to detect differences in clinical outcomes. 
This study might have produced more significant results if a lower power percentage (80%) was 
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used during the power calculation. This would have resulted in more subjects being recruited 
into the study. 
 
5.6.4 Administration of CPAx Assessments 
The CPAx tool was not administered to participants over weekends as a result of restrictions on 
staff availability, factors related to staff training (the two research assistants who performed 
CPAx assessments were not always on duty over weekends) and the logistics of data collection. 
There were some occasions where this resulted in participants only receiving one assessment 
using the CPAx tool before being discharged to the wards. Similar limitations were reported in 
an observational study performed in a cohort of 52 patients who had suffered from burn injuries 
(Corner, et al., 2015). In the aforementioned study, CPAx assessments were not administered 
over weekends and treating therapists were not blinded (Corner, et al., 2015). As described by 
Corner et al (2015) it is unlikely that CPAx scores would have altered clinical decision making; 
however, it cannot be ruled out.  
 
There was no blinding of treating clinicians in this study. Those that performed the assessments 
using the CPAx tool were also closely involved in rehabilitation and clinical decision making 
throughout the participants’ ICU LOS.  
 
5.6.5 Content Validation of the Questionnaire 
The questionnaire used in the second part of this study was drawn up by the researcher and her 
supervisor. Content validation of the questionnaire was not performed prior to the start of the 
study and the questionnaire was not piloted. 
 
5.7 RECOMMENDATIONS FOR FUTURE TRIALS 
A larger sample size could be used in future trials of a similar nature in order to verify the results 
obtained in this study. A randomised controlled multi-centre trial design could be used to 
determine more accurately the effect of CPAx on patient duration of stay in ICU and in hospital. 
Measuring the effect of the CPAx tool on participants’ duration of mechanical ventilation could 
also be an interesting clinical outcome to consider.  Such a study design could yield a wider 
perception of physiotherapists regarding the usefulness of the CPAx tool in daily clinical practice 
in South African ICUs.  
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CHAPTER 6 
 
6. CONCLUSION 
The data presented in this study show that the use of the CPAx tool does not have a significant 
influence on ICU and hospital LOS in a sample of surgical and trauma participants. The tool 
appears to be more useful when used in the care of patients who have undergone surgical 
procedures rather than those who have sustained complex traumatic injuries.  
 
CPAx scores on ICU admission and discharge appeared to have an inconsistent association 
with APACHE II scores on ICU admission. Initial SOFA scores had an inverse association with 
CPAx scores on ICU admission as well as ICU discharge. SOFA scores at ICU discharge had 
an unexpected positive association with initial CPAx scores and CPAx scores on ICU discharge.  
 
The small number of physiotherapy clinicians that participated in this single-centre study 
supported the use of the CPAx tool for assessment of physical function of patients in ICU and 
generally had positive perceptions towards the use of the tool.   
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APPENDIX 2 
INDIVIDUAL PARTICIPANT RECORD SHEET 
 
1. Participant identity code : ______________________________________________________ 
2. Age   : ______________________________________________________ 
3. Gender   : ______________________________________________________ 
4. Date of ICU admission : ______________________________________________________ 
5. Time of ICU admission : ______________________________________________________ 
6. Diagnosis:___________________________________________________________________ 
___________________________________________________________________________ 
7. APACHE score (within 24 hours of admission) according to online calculator: ______________ 
 
Variable Unit Value 
Fi02 %  
Pa02 mmHg  
Temperature (rectal) ˚C  
MAP mmHg  
pH   
HR Bpm  
RR Bpm  
Na mEq/L  
K mEq/L  
Creatinine mg/dL  
Hct %  
WCC X109/L  
GCS   
Presence of acute renal failure Yes/No  
Immunocompromised or severe organ insufficiency Yes/No  
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8. SOFA score and CPAx score 
 
 
 
9. Date of discharge from ICU  : __________________________________________ 
 
10. Date of discharge from hospital ward : __________________________________________ 
 
11. Other (re-admissions into ICU etc) :  _________________________________________ 
 
SOFA variable Unit Date Date Date Date Date Date Date Date Date Date 
Fi02 %           
Pa02 mmHg           
Ventilation Yes/No           
Platelets X103mm3           
Bilirubin Mg/dL           
GCS -           
MAP mmHg           
Vasopressors Yes/No           
Creatinine Mg/dL           
Urine output ml/day           
CPAx score -           
SOFA variable Unit Date Date Date Date Date Date Date Date Date Date 
Fi02 %           
Pa02 mmHg           
Ventilation Yes/No           
Platelets X103mm3           
Bilirubin Mg/dL           
GCS -           
MAP mmHg           
Vasopressors Yes/No           
Creatinine Mg/dL           
Urine output ml/day           
CPAx score -           
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APPENDIX 3 
QUESTIONNAIRE 
 
Please answer each question by placing a tick next to the appropriate answer (only one 
answer per question please) 
Please give details on additional information when requested. 
 
SECTION 1  
 
1. What is your level of qualification?  
BSc  MSc  PhD  
 
2. What is your preferred area of physiotherapy? 
Cardiopulmonary/ICU  Sports/NMS  Neurology  
Orthopaedics  Paediatrics  Public health  
 
3. How many years of clinical experience do you have in physiotherapy? 
<5 years  
5-10 
years 
 
11-15 
years 
 
16-20 
years 
 
>20 
years 
 
 
4. How many years of experience do you have working in the ICU setting? 
<3 years  
3-6 
Years 
 
7-9 
years 
 
10-12 
years 
 
>12 
years 
 
 
5. How many hours a week do you work in an ICU setting? 
< 5 hours  
5-10 
hours 
 
11-15 
hours 
 
16-20 
hours 
 
> 20 
hours 
 
 
6. What is your average daily patient load in ICU? 
0-3 pts  4-6pts  7-9pts  >9pt  
 
7. What is your average daily patient load outside of ICU? 
0-3 pts  4-6pts  7-9pts  >9pt  
 
8. Outside the ICU setting, do you use outcome measures to assess patients’ response to 
treatment? 
Never  Seldom  Sometimes  Often  
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SECTION 2 
 
1. Have you heard about the CPAx tool prior to your participation in this study? 
Yes  No  
 
2. If yes, how did you learn about the CPAx tool? 
Literature  Information evening, lecture, course  
Word of mouth 
(colleagues, etc). 
 
 
3. A- Are you aware of a tool that can be used in the ICU setting that measures physical morbidity 
besides the CPAx tool? 
Yes  No  
 
B – If yes, which one/s? 
___________________________________________________________________________ 
 
C- How regularly do you use these other tools? 
 
4. If you prefer not to use an outcome measure, please supply further information below: 
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________ 
 
  
Never  Rarely  Sometimes  Often  
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SECTION 3 
 
Please tick either ‘Yes’ or ‘No’ for each of the statements about CPAx found in the table below: 
 
The CPAx tool: Yes No 
Enhances accuracy of assessment   
Is not appropriate/useful when used with patients with certain admission diagnoses   
Assists with patient care planning and goal setting   
Assists in evaluating patient progression   
Assists in motivating patients to partake in treatment   
Assists in motivating physiotherapists regarding patient treatment   
Enhances communication with the patients   
Is time consuming to administer   
Is difficult to interpret   
Has variables that are not relevant to patient care   
Requires too much effort than proved necessary     
Is comprehensive enough to be administered independently   
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APPENDIX 5 
 
CONSENT FORM 
 
I hereby confirm that I have been informed about the nature, conduct, benefits and risks of the study: 
Use of the CPAx Tool in a South African Intensive Care Unit: Clinical Outcomes and 
Physiotherapists’ Perceptions 
 
I hereby acknowledge that I have received, read and understood the information sheet pertaining to 
the study.  
 
I am aware that the results of the study, including personal details such as gender, age and diagnosis 
will be anonymously processed into a research paper. 
 
I hereby acknowledge that I have been given the opportunity to ask questions related to the study 
and acknowledge that the researchers have answered my questions adequately. 
I understand that I, without prejudice, may withdraw my consent and participation from the study at 
any time. 
 
Signed: 
Participant’s name : ____________________________________________________________ 
 
 
Signature/thumbprint : ____________________________________________________________ 
Date   : ____________________________________________________________ 
 
 
 
 
Researcher’s name : ____________________________________________________________ 
 
 
Signature  : ____________________________________________________________ 
Date   : ____________________________________________________________ 
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APPENDIX 6 
 
TEMPORARY CONSENT FORM FOR PATIENT SPOUSE/PARENTS 
 
I hereby confirm that I have been informed about the nature, conduct, benefits and risks of the study: 
Use of the CPAx Tool in a South African Intensive Care Unit: Clinical Outcomes and 
Physiotherapists’ Perceptions 
 
I hereby acknowledge that I have received, read and understood the information sheet pertaining to 
the study.  
 
I am aware that the results of the study, including personal details regarding my relative’s gender, 
age and diagnosis will be anonymously processed into a research paper. 
 
I hereby acknowledge that I have been given the opportunity to ask questions related to the study 
and acknowledge that the researchers have answered my questions adequately. 
 
I understand that participation of my son/daughter or spouse in the study may be withdrawn at any 
time without prejudice.  
 
Proxy for participant: 
Printed name : ____________________________________________________________ 
 
 
Signature/thumbprint : ____________________________________________________________ 
Date   : ____________________________________________________________ 
 
 
 
 
Researcher’s name : ____________________________________________________________ 
 
 
Signature  : ____________________________________________________________ 
Date   : ____________________________________________________________ 
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APPENDIX 11 
 
Use of the CPAx Tool in a South African Intensive Care Unit: Clinical Outcomes and 
Physiotherapists’ Perceptions 
 
PARTICIPANT INFORMATION SHEET 
 
Dear potential participant, 
My name is Megan Whelan. I am a physiotherapy clinician working at Chris Hani Baragwanath 
Academic Hospital. I am performing a research study entitled ‘Use of the CPAx Tool in a South 
African Intensive Care Unit: Clinical Outcomes and Physiotherapists’ Perceptions’. The purpose of 
my study is to determine the effect of using an assessment tool called CPAx on the period of time 
spent in the ICU and in the hospital. CPAx is a paper-based assessment tool that is used by 
physiotherapists in countries such as England to evaluate a person’s ability to do everyday activities. 
It is not an invasive measure. There are ten different areas/activities that the tool assesses relating 
to patient function. These areas include: respiratory function, cough effort, moving in the bed, lie to 
sit, sitting balance, sit to stand, standing balance, stepping, transfer to a chair and grip strength. The 
tool assists physiotherapists to set specific rehabilitation goals for treatment sessions.   
 
What does the Study Involve? 
In this study, you will receive physiotherapy assessment using the CPAx tool. This assessment 
includes measuring your ability to perform everyday tasks such as coughing, rolling, sitting up in bed, 
standing, stepping, moving into a chair and grip strength. This will be measured every second day 
of the week for the duration of time that while you are in the ICU. You will receive physiotherapy 
treatment, based on the assessment findings of the CPAx tool, which involves exercises and 
rehabilitation depending on what tasks you are struggling with. I will be monitoring how many days 
you spend in the ICU as well as how many days you spend in the hospital. 
 
What are the Risks? 
There are no known risks associated with use of the CPAx tool or to participating in this study.  
 
What is the Cost? 
Your participation in this study will not lead to any additional cost to you or your family. 
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Confidentiality and Anonymity 
If you decide to participate in this study, I will give you a study identity code and this code will be 
used when we enter your information into the database of information for the study. Therefore your 
information will remain anonymous and information obtained from the study will be used for statistical 
purposes only.  
 
What are Your Rights? 
You may withdraw your consent for participating in the study at any stage. No questions will be asked 
regarding your decision and you will not be penalised for your decision to withdraw participation. 
 
Contact Details: 
If you have any further queries or questions about the study you can contact me on 0714822036. If 
you wish to report any complaints about or problems with the study you can contact the Human 
Research Ethics Committee of the University of the Witwatersrand by emailing: 
peter.cleaton-jones1@wits.ac.za 
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APPENDIX 12 
 
Use of the CPAx Tool in a South African Intensive Care Unit: Clinical Outcomes and 
Physiotherapists’ Perceptions 
 
PARTICIPANT INFORMATION SHEET FOR PHYSIOTHERAPISTS 
 
Dear potential participant, 
My name is Megan Whelan. I am a physiotherapy clinician working at Chris Hani Baragwanath 
Academic hospital. I am performing a research study entitled ‘Use of the CPAx Tool in a South 
African Intensive Care Unit: Clinical Outcomes and Physiotherapists’ Perceptions’. The purpose of 
my study is to determine the effect of using an outcome measure called the Chelsea Critical Care 
Physical Assessment tool (CPAx) on length of time that patients spend in the Intensive Care Unit 
(ICU) and in the hospital. I also wish to investigate the perceptions of physiotherapists towards the 
use of the tool as well as facilitators and barriers to using the tool. CPAx is a paper-based 
assessment tool that is used by physiotherapists in the United Kingdom to evaluate a person’s ability 
to do everyday activities. It is not an invasive measure. There are ten different areas/activities that 
the tool assesses namely: respiratory function, cough effort, moving in the bed, lie to sit, sitting 
balance, sit to stand, standing balance, stepping, transfer to a chair and grip strength. 
 
What does the Study Involve? 
In order to participate in this study, you will be required to complete the online CPAx training module. 
The online link will be emailed to you. Following completion of this module, you will be required to 
administer the CPAx tool to clinical participants in the trial. Once data collection has been completed, 
you will be required to complete a printed survey that will assess your experience of using the CPAx 
tool in your daily clinical practice. 
 
What are the Risks? 
There are no known risks associated with the CPAx tool or to participating in the study.  
 
What is the Cost? 
There are no costs involved. 
 
Confidentiality and Anonymity: 
All participants’ documentation will remain anonymous and information obtained from the study will 
be used for statistical purposes only.  
What are Your Rights? 
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You may withdraw your consent for participating in the study at any stage. No questions will be asked 
regarding your decision. 
 
Contact Details 
If you have any further queries or questions pertaining to the study you can contact me on 
0714822036. If you wish to report any complaints or problems you can contact the Human Research 
Ethics Committee of the University of the Witwatersrand by emailing: 
peter.cleaton-jones1@wits.ac.za 
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APPENDIX 13 
TURN-IT-IN REPORT 
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